ID stringlengths 13 17 | question stringlengths 88 1.13k | answer stringlengths 6 156 | reference_sequence stringlengths 4.1k 4.1k | variant_sequence stringlengths 4.1k 4.1k |
|---|---|---|---|---|
Task1_train_10800 | Consider this mutation in AHI1 (Abelson helper integration site 1) on Chromosome 6. Is this a benign change or a disease-causing variant? | Pathogenic; Joubert syndrome 3 | AAATATGCTATCACTGTTTATAAAAGGGCGTCTCACTTGATTCCACAGCATTGGAAAACTAAATCCTAGAGATTAAATTCTCACACAACTTTTTTTTTTGCCTTACTGGACTACTAAAAATAATAGCTTACATTTGTGCTATTAAATATTAACTATCGTTTAATTTGAATTGGTCCATTCAATTCATACCTCAAAGAACAGGATGACTTTAGGACTCTCATCAGAGCCTCGAAGCAAATAGGGAAAATTTTCATTAAATACAATTTGTTCTTCCCACTCTGGAAGTCTTGATTTTAACTGTTTAAAATCATATGGCTGGG... | AAATATGCTATCACTGTTTATAAAAGGGCGTCTCACTTGATTCCACAGCATTGGAAAACTAAATCCTAGAGATTAAATTCTCACACAACTTTTTTTTTTGCCTTACTGGACTACTAAAAATAATAGCTTACATTTGTGCTATTAAATATTAACTATCGTTTAATTTGAATTGGTCCATTCAATTCATACCTCAAAGAACAGGATGACTTTAGGACTCTCATCAGAGCCTCGAAGCAAATAGGGAAAATTTTCATTAAATACAATTTGTTCTTCCCACTCTGGAAGTCTTGATTTTAACTGTTTAAAATCATATGGCTGGG... |
Task1_train_10801 | A variant affecting Chromosome 6, within the gene BCLAF1 (BCL2 associated transcription factor 1), has been observed. Determine if it's benign or associated with disease. | Pathogenic; Pulmonary artery atresia | GACTTTACCTGCTCAGGTGACTGAGTTTCTTTCTTTACTGTTATTCTTTCAGAATTTTTGTCTTCTTCTTTGTGCTTATCTTTTGTAGTGCTAGGCCTTTCCACTACATATCCAGTCTCTTTAAGTTTATAATTTTTTTCTTCTCTAAATCCATCACTTTCTCTATTGCCTTTCAGTGAAACTTTGGACTTGTACTTGAGTCCTTCCTCCTCAGTATTCCGGTGAGATGCAGTAGCAAAACTTTTACCCTGATCTGCGAGGACTGACTTCCTGAACTGTCTATAATCCTCTGTCTCCTCTGTGTCATCCCCTTCTGAATC... | GACTTTACCTGCTCAGGTGACTGAGTTTCTTTCTTTACTGTTATTCTTTCAGAATTTTTGTCTTCTTCTTTGTGCTTATCTTTTGTAGTGCTAGGCCTTTCCACTACATATCCAGTCTCTTTAAGTTTATAATTTTTTTCTTCTCTAAATCCATCACTTTCTCTATTGCCTTTCAGTGAAACTTTGGACTTGTACTTGAGTCCTTCCTCCTCAGTATTCCGGTGAGATGCAGTAGCAAAACTTTTACCCTGATCTGCGAGGACTGACTTCCTGAACTGTCTATAATCCTCTGTCTCCTCTGTGTCATCCCCTTCTGAATC... |
Task1_train_10802 | The following genetic variant occurs in BCLAF1 (BCL2 associated transcription factor 1) on Chromosome 6. Classify its clinical effect — pathogenic or benign — and list any associated condition. | Pathogenic; Pulmonary artery atresia | ATTAAACTTTTGTTTTCCAGACTCTTTATCACTGAAGTAATCTAGAGCTTCCTGATCTTCCCATTCTCCCTCTGCCCTCCCTTTCTCTGATCCTTTCTCTTTTGAAGCCTCTTTATCCCTGGTATTACCCCTATCAAGCAGGAATACTCTAGACTCTTCATCTGTGAACCTGCGAATAAGCAAAGAAGAGGATAGTAACTCTGGATTGCATTCACTGTAGATCGCTTCCATATTTAAATGTGTTGCCCAATCCCTCAGGACCAGCAAGAGAGAAAATAACCCTATTGAAAAGTGCTTTTTCAGATTCCACTTTTAAAAAT... | ATTAAACTTTTGTTTTCCAGACTCTTTATCACTGAAGTAATCTAGAGCTTCCTGATCTTCCCATTCTCCCTCTGCCCTCCCTTTCTCTGATCCTTTCTCTTTTGAAGCCTCTTTATCCCTGGTATTACCCCTATCAAGCAGGAATACTCTAGACTCTTCATCTGTGAACCTGCGAATAAGCAAAGAAGAGGATAGTAACTCTGGATTGCATTCACTGTAGATCGCTTCCATATTTAAATGTGTTGCCCAATCCCTCAGGACCAGCAAGAGAGAAAATAACCCTATTGAAAAGTGCTTTTTCAGATTCCACTTTTAAAAAT... |
Task1_train_10803 | Consider this mutation in PEX7 (peroxisomal biogenesis factor 7) on Chromosome 6. Is this a benign change or a disease-causing variant? | Pathogenic; Peroxisome biogenesis disorder 9B | AAGGAGCAGGTAATAGCTCAGTTTGTGTGTGTGTGTGTATGTCCAAGGTCACTGTAAATAGTTTACCCCAGCTGGAACCAGCCTTTCTCCCTCCCAGAGATACCACACTATTTTTAGCTTAGATTGGATAACTCTTTATATACAACTCTTTGCCAAGGTCCCAGCTGCTTCATGTTTGCTTACTTTGATATTTTATTAACGCCTATTTAGCATTTCAATAAACTCCAGAATGTTTCCAGGTTACTTTTTGTAGTATTACGAAAAACACACTGATCATTTAGGCACTGTATTAGGCTGCATTCACTCAACATTTCCTGAAT... | AAGGAGCAGGTAATAGCTCAGTTTGTGTGTGTGTGTGTATGTCCAAGGTCACTGTAAATAGTTTACCCCAGCTGGAACCAGCCTTTCTCCCTCCCAGAGATACCACACTATTTTTAGCTTAGATTGGATAACTCTTTATATACAACTCTTTGCCAAGGTCCCAGCTGCTTCATGTTTGCTTACTTTGATATTTTATTAACGCCTATTTAGCATTTCAATAAACTCCAGAATGTTTCCAGGTTACTTTTTGTAGTATTACGAAAAACACACTGATCATTTAGGCACTGTATTAGGCTGCATTCACTCAACATTTCCTGAAT... |
Task1_train_10804 | Located on Chromosome 6, this mutation impacts PEX7 (peroxisomal biogenesis factor 7). What is its biological consequence — is it benign or pathogenic, and which disease is associated if any? | Pathogenic; Rhizomelic chondrodysplasia punctata type 1 | AAGGAGCAGGTAATAGCTCAGTTTGTGTGTGTGTGTGTATGTCCAAGGTCACTGTAAATAGTTTACCCCAGCTGGAACCAGCCTTTCTCCCTCCCAGAGATACCACACTATTTTTAGCTTAGATTGGATAACTCTTTATATACAACTCTTTGCCAAGGTCCCAGCTGCTTCATGTTTGCTTACTTTGATATTTTATTAACGCCTATTTAGCATTTCAATAAACTCCAGAATGTTTCCAGGTTACTTTTTGTAGTATTACGAAAAACACACTGATCATTTAGGCACTGTATTAGGCTGCATTCACTCAACATTTCCTGAAT... | AAGGAGCAGGTAATAGCTCAGTTTGTGTGTGTGTGTGTATGTCCAAGGTCACTGTAAATAGTTTACCCCAGCTGGAACCAGCCTTTCTCCCTCCCAGAGATACCACACTATTTTTAGCTTAGATTGGATAACTCTTTATATACAACTCTTTGCCAAGGTCCCAGCTGCTTCATGTTTGCTTACTTTGATATTTTATTAACGCCTATTTAGCATTTCAATAAACTCCAGAATGTTTCCAGGTTACTTTTTGTAGTATTACGAAAAACACACTGATCATTTAGGCACTGTATTAGGCTGCATTCACTCAACATTTCCTGAAT... |
Task1_train_10805 | This sequence variant lies in PEX7 (peroxisomal biogenesis factor 7) on Chromosome 6. Is it clinically significant, and what condition might it cause if any? | Pathogenic; Peroxisome biogenesis disorder 9B | AAGGAGCAGGTAATAGCTCAGTTTGTGTGTGTGTGTGTATGTCCAAGGTCACTGTAAATAGTTTACCCCAGCTGGAACCAGCCTTTCTCCCTCCCAGAGATACCACACTATTTTTAGCTTAGATTGGATAACTCTTTATATACAACTCTTTGCCAAGGTCCCAGCTGCTTCATGTTTGCTTACTTTGATATTTTATTAACGCCTATTTAGCATTTCAATAAACTCCAGAATGTTTCCAGGTTACTTTTTGTAGTATTACGAAAAACACACTGATCATTTAGGCACTGTATTAGGCTGCATTCACTCAACATTTCCTGAAT... | AAGGAGCAGGTAATAGCTCAGTTTGTGTGTGTGTGTGTATGTCCAAGGTCACTGTAAATAGTTTACCCCAGCTGGAACCAGCCTTTCTCCCTCCCAGAGATACCACACTATTTTTAGCTTAGATTGGATAACTCTTTATATACAACTCTTTGCCAAGGTCCCAGCTGCTTCATGTTTGCTTACTTTGATATTTTATTAACGCCTATTTAGCATTTCAATAAACTCCAGAATGTTTCCAGGTTACTTTTTGTAGTATTACGAAAAACACACTGATCATTTAGGCACTGTATTAGGCTGCATTCACTCAACATTTCCTGAAT... |
Task1_train_10806 | A variant affecting Chromosome 6, within the gene IFNGR1 (interferon gamma receptor 1), has been observed. Determine if it's benign or associated with disease. | Pathogenic; Immunodeficiency 27A | CTTGAATATTTATAAGCATCCTATTTTCATTACACTACAGAAAGGAACAACTTTTGCTAGCTACACAAGAATTTCCATTATGAAAAATGTGAAACACATACCTCACTTCCGTTCATTCTCACATACACATTGTACACCCTAATGTAACAGGTAGTTTCGGGATCATAATCGACTTCCTGCTCGTCTCCATTTACAAAAACTGAAGGGTGAAATATGTCAATCATGATTTGCTTCTCCTCCTTTCTGATATCCAGTTTAGGTGGTCCAATTTTTCCTGGGGAAGGAGGAGGAGGAAGTATAATAAATACTGGCCTTGGAAC... | CTTGAATATTTATAAGCATCCTATTTTCATTACACTACAGAAAGGAACAACTTTTGCTAGCTACACAAGAATTTCCATTATGAAAAATGTGAAACACATACCTCACTTCCGTTCATTCTCACATACACATTGTACACCCTAATGTAACAGGTAGTTTCGGGATCATAATCGACTTCCTGCTCGTCTCCATTTACAAAAACTGAAGGGTGAAATATGTCAATCATGATTTGCTTCTCCTCCTTTCTGATATCCAGTTTAGGTGGTCCAATTTTTCCTGGGGAAGGAGGAGGAGGAAGTATAATAAATACTGGCCTTGGAAC... |
Task1_train_10807 | A mutation on Chromosome 6 affecting IFNGR1 (interferon gamma receptor 1) has been found. Is it harmful or harmless? What disease, if any, does it cause? | Pathogenic; Immunodeficiency 27A | GTGAAAAATCAGAACTTATTCCATAAATATTTATTAGGTCTTTGATGTTTGAGACTTTGTTGTGAACCATTTATCTAGTCTTCACATATTACTGTGTACCACTGTGTGCCAGGCAGGTCTGTTTTTAACCCATCAGTGTATCCTCAGGGCCCAGTATACTTTCCGGCACGTAGTAGGCCCTTGATAAATCTATATGGAAAAAAATCTAACATGCAGATGGTGTGGTAATCATATGACAAAATTGTGGACTCTGGGGAAGAAAAGTATTTAAAGGGTAAGGAGAGGAAGAGCCTGTAGAAGAGACCGAGGTGGCACAATCT... | GTGAAAAATCAGAACTTATTCCATAAATATTTATTAGGTCTTTGATGTTTGAGACTTTGTTGTGAACCATTTATCTAGTCTTCACATATTACTGTGTACCACTGTGTGCCAGGCAGGTCTGTTTTTAACCCATCAGTGTATCCTCAGGGCCCAGTATACTTTCCGGCACGTAGTAGGCCCTTGATAAATCTATATGGAAAAAAATCTAACATGCAGATGGTGTGGTAATCATATGACAAAATTGTGGACTCTGGGGAAGAAAAGTATTTAAAGGGTAAGGAGAGGAAGAGCCTGTAGAAGAGACCGAGGTGGCACAATCT... |
Task1_train_10808 | Chromosome 6 houses a mutation in gene IFNGR1 (interferon gamma receptor 1). Classify its clinical impact — is it pathogenic or benign, and what disease does it lead to if any? | Pathogenic; Immunodeficiency 27A | GATCCTGCATAAAATCATTTCCCTTTGTAATTGATAATCCAATGATGTCAGCATTAGTAAATAATGACTGACTTCAGCAAGGCATAGTGGGTGTATTATTTTGTTGGCTCAACACCTGTACTTCAGGCACGCCATTCCGCTTCTTCTGGTAACCCAACCCAACCCTCTACGAGAATGTCCTTCCCATGCAAGCTGGCACCTGAACCTAGCTGGGCAAATCAGAGCCTTTCCCTGGCATTTTGTTAGAATGGAGGAGGCTGCAAGATGTCAAAACTCAGAAGCTGTCAGCATCCATGATTCCTGCCAAGTGTGGAAAGCTG... | GATCCTGCATAAAATCATTTCCCTTTGTAATTGATAATCCAATGATGTCAGCATTAGTAAATAATGACTGACTTCAGCAAGGCATAGTGGGTGTATTATTTTGTTGGCTCAACACCTGTACTTCAGGCACGCCATTCCGCTTCTTCTGGTAACCCAACCCAACCCTCTACGAGAATGTCCTTCCCATGCAAGCTGGCACCTGAACCTAGCTGGGCAAATCAGAGCCTTTCCCTGGCATTTTGTTAGAATGGAGGAGGCTGCAAGATGTCAAAACTCAGAAGCTGTCAGCATCCATGATTCCTGCCAAGTGTGGAAAGCTG... |
Task1_train_10809 | The gene LOC126859807, TNFAIP3 (MED14-independent group 3 enhancer GRCh37_chr6:138196296-138197495| TNF alpha induced protein 3) on Chromosome 6 contains a mutation. Based on this information, is the variant pathogenic or benign? Provide the disease if relevant. | Pathogenic; not provided | TGTGAGTTTTAAACTGGAAAGGTCACAGATTAATGGCATACAATTAAACCTGTTTTTTTGTTTGTTTTTCTTCTCAAAATGTTAGCCCTAAACACTGAATTATTTTCAAATTTAGACACCCAGGTGCTTTTTAACTTTTGTACTTTACAGTTACTAACAAGCAGGTTTGCATAAGGCATTTTTGAGAGCCGGACTAGCAGGCCATAGGTAATTCCGTGTTGTCAATACGACTTTCCACACCAGGAGAGGAAACTCCCAGGGCCCAAAGGCTAAAGTGGAATGGTCAAGTCATTTGCCATTGAGTCATAGCCAGACCATCC... | TGTGAGTTTTAAACTGGAAAGGTCACAGATTAATGGCATACAATTAAACCTGTTTTTTTGTTTGTTTTTCTTCTCAAAATGTTAGCCCTAAACACTGAATTATTTTCAAATTTAGACACCCAGGTGCTTTTTAACTTTTGTACTTTACAGTTACTAACAAGCAGGTTTGCATAAGGCATTTTTGAGAGCCGGACTAGCAGGCCATAGGTAATTCCGTGTTGTCAATACGACTTTCCACACCAGGAGAGGAAACTCCCAGGGCCCAAAGGCTAAAGTGGAATGGTCAAGTCATTTGCCATTGAGTCATAGCCAGACCATCC... |
Task1_train_10810 | The following genetic variant occurs in TNFAIP3 (TNF alpha induced protein 3) on Chromosome 6. Classify its clinical effect — pathogenic or benign — and list any associated condition. | Pathogenic; Autoinflammatory syndrome, familial, Behcet-like 1 | AAAGCCTGGGACTTTAACCAATAAGATCCACCACCTCCAGGCTGGTTAATGTTATGTGAGTTTCCTGGAAACAGTGCATTTTTATATTAGATTGTAGCACATTTTGTTTTCCCATTTGGGTTTAACTGTGGCTAAGAATACTTTTCTATTCTGTAAGTTATATCTTTTATACATTTTCAAAATGAGATCTACTTACCTATGGCCTTGTTTAGTAGAATACTGTTTTACTTATGTATTATTTTTTTCCTTAGAAATCCGAGCTGTTCCACTTGTTAACAGAGACCGGGGAAGATTTGAAGACTTAAAAGTTCACTTTTTGA... | AAAGCCTGGGACTTTAACCAATAAGATCCACCACCTCCAGGCTGGTTAATGTTATGTGAGTTTCCTGGAAACAGTGCATTTTTATATTAGATTGTAGCACATTTTGTTTTCCCATTTGGGTTTAACTGTGGCTAAGAATACTTTTCTATTCTGTAAGTTATATCTTTTATACATTTTCAAAATGAGATCTACTTACCTATGGCCTTGTTTAGTAGAATACTGTTTTACTTATGTATTATTTTTTTCCTTAGAAATCCGAGCTGTTCCACTTGTTAACAGAGACCGGGGAAGATTTGAAGACTTAAAAGTTCACTTTTTGA... |
Task1_train_10811 | This is a variant in PERP (p53 apoptosis effector related to PMP22), located on Chromosome 6. Is this mutation a likely cause of disease or not? | Pathogenic; Erythrokeratodermia variabilis et progressiva 7 | CACGGCATAGTTGTGTGGGTTTTTCTTTTCAATTTTGGTATAATCACCCAGATTACATTTCTCTATGAGAAACATTCACCTCGCATTTTGAAAAGCATAGAAAAATTCACTGCCAAGGACTAGCTGGCCAACAGTAGCCCTAGGGAGATATATTTCCGTTCTCCCACCCAGCCTCTCTGCACCCATCCTCACAATGACATACACCATAGTGGAAGTAACATATGACTTATGGTGGGAAAAAAAATAACAAATGATAAAATGGGAAGGAGGGCAAGGGGAAAATAGAGAGACTGCTACCCCACCACCTGAATGGAAGGGGA... | CACGGCATAGTTGTGTGGGTTTTTCTTTTCAATTTTGGTATAATCACCCAGATTACATTTCTCTATGAGAAACATTCACCTCGCATTTTGAAAAGCATAGAAAAATTCACTGCCAAGGACTAGCTGGCCAACAGTAGCCCTAGGGAGATATATTTCCGTTCTCCCACCCAGCCTCTCTGCACCCATCCTCACAATGACATACACCATAGTGGAAGTAACATATGACTTATGGTGGGAAAAAAAATAACAAATGATAAAATGGGAAGGAGGGCAAGGGGAAAATAGAGAGACTGCTACCCCACCACCTGAATGGAAGGGGA... |
Task1_train_10812 | The variant affects gene REPS1 (RALBP1 associated Eps domain containing 1), which is on Chromosome 6. Please evaluate whether this mutation is benign or pathogenic and specify the disease if necessary. | Pathogenic; Neurodegeneration with brain iron accumulation | AACAGTGTTGTTTAATGTTATTCTGAACTTACGGATCCACGAACAGAATGTAAGAGTCTTAGACTTTTTTAACTGGGAAAAGATATTTTTAATATGTGAATATGTCATGTTTTTGGCCCCCAGTGATTATAAATTCTTTTTAGACAAATAATCTGATAATTATTTTATAATTAAAATCTATGACCAATAAAACAATGTCTTTGATATTATGAAATTGAGATTCTCCTGTCCCATCTAGAAGAACTTCTGTTTTCAACAACTCACCTGGAATAAATCCGTTTAGATCAGGCTGAATGGTTTTAAACTGATTTACATAATAC... | AACAGTGTTGTTTAATGTTATTCTGAACTTACGGATCCACGAACAGAATGTAAGAGTCTTAGACTTTTTTAACTGGGAAAAGATATTTTTAATATGTGAATATGTCATGTTTTTGGCCCCCAGTGATTATAAATTCTTTTTAGACAAATAATCTGATAATTATTTTATAATTAAAATCTATGACCAATAAAACAATGTCTTTGATATTATGAAATTGAGATTCTCCTGTCCCATCTAGAAGAACTTCTGTTTTCAACAACTCACCTGGAATAAATCCGTTTAGATCAGGCTGAATGGTTTTAAACTGATTTACATAATAC... |
Task1_train_10813 | A genetic alteration is present in REPS1 (RALBP1 associated Eps domain containing 1) on Chromosome 6. Is this variant benign or disease-causing, and if the latter, which condition is involved? | Pathogenic; Neurodegeneration with brain iron accumulation 7 | TTTGTAAAAATGGATACAGAAACAAGAGGCACAAAATGTCTATCACCACAAAATTTGGACCACCATCTCCCTTACATTATTTAGGGAGACTCTTATCTAGAAAGAAGTAATAAAACCAAATTGTCCTTCTAATGAGTGATAACAATGGCTACATCAAATGTCTACGTATGTTTGGCCCTATACTTGCCACTGAATATTTATTTCACCTCGTAACCACAGTACCCCTGCAAAGCTCCTATTTACAGATAAGAAAACTGAGGCTCCATGATGCCAAGGTCATGCTTGTAGTAACTGACAGTTAAGATATAAACCTAGATCAG... | TTTGTAAAAATGGATACAGAAACAAGAGGCACAAAATGTCTATCACCACAAAATTTGGACCACCATCTCCCTTACATTATTTAGGGAGACTCTTATCTAGAAAGAAGTAATAAAACCAAATTGTCCTTCTAATGAGTGATAACAATGGCTACATCAAATGTCTACGTATGTTTGGCCCTATACTTGCCACTGAATATTTATTTCACCTCGTAACCACAGTACCCCTGCAAAGCTCCTATTTACAGATAAGAAAACTGAGGCTCCATGATGCCAAGGTCATGCTTGTAGTAACTGACAGTTAAGATATAAACCTAGATCAG... |
Task1_train_10814 | With a mutation on Chromosome 6 in gene ADGRG6 (adhesion G protein-coupled receptor G6), classify this variant as benign or pathogenic. Include the disease if it's pathogenic. | Pathogenic; Lethal congenital contracture syndrome 9 | TCCAATCATTTAGGCCTTTACAGTTAAAGAAATTGCACACCAAAGGAAAGGGTTTTTTTTTTTTCTTTAATTTAGCAGTAAGTACTGTTTACATAATGAGCAGCATTCTTGGCTTTAATCAGTTTTCCCATTAGTATTTCAAGTGACCTTTGGTCTTTACACATCCGCAGAGTAAGATGGAATTGTGCTAAGCACATATTATCATTTTTATTGGCATCATTTCTAGATTCTAGAAGGCCCACTGCCAGCAAACACTGGTGACCTCTGTTTGCCTTTACAAGTACAACCTGATCGAGAGCAGGTTCGCTGGGCCCTTTTTA... | TCCAATCATTTAGGCCTTTACAGTTAAAGAAATTGCACACCAAAGGAAAGGGTTTTTTTTTTTTCTTTAATTTAGCAGTAAGTACTGTTTACATAATGAGCAGCATTCTTGGCTTTAATCAGTTTTCCCATTAGTATTTCAAGTGACCTTTGGTCTTTACACATCCGCAGAGTAAGATGGAATTGTGCTAAGCACATATTATCATTTTTATTGGCATCATTTCTAGATTCTAGAAGGCCCACTGCCAGCAAACACTGGTGACCTCTGTTTGCCTTTACAAGTACAACCTGATCGAGAGCAGGTTCGCTGGGCCCTTTTTA... |
Task1_train_10815 | Here is a variant affecting ADGRG6 (adhesion G protein-coupled receptor G6) on Chromosome 6. Please identify whether it is a benign mutation or associated with a disorder. | Pathogenic; Arthrogryposis multiplex congenita | TCCAATCATTTAGGCCTTTACAGTTAAAGAAATTGCACACCAAAGGAAAGGGTTTTTTTTTTTTCTTTAATTTAGCAGTAAGTACTGTTTACATAATGAGCAGCATTCTTGGCTTTAATCAGTTTTCCCATTAGTATTTCAAGTGACCTTTGGTCTTTACACATCCGCAGAGTAAGATGGAATTGTGCTAAGCACATATTATCATTTTTATTGGCATCATTTCTAGATTCTAGAAGGCCCACTGCCAGCAAACACTGGTGACCTCTGTTTGCCTTTACAAGTACAACCTGATCGAGAGCAGGTTCGCTGGGCCCTTTTTA... | TCCAATCATTTAGGCCTTTACAGTTAAAGAAATTGCACACCAAAGGAAAGGGTTTTTTTTTTTTCTTTAATTTAGCAGTAAGTACTGTTTACATAATGAGCAGCATTCTTGGCTTTAATCAGTTTTCCCATTAGTATTTCAAGTGACCTTTGGTCTTTACACATCCGCAGAGTAAGATGGAATTGTGCTAAGCACATATTATCATTTTTATTGGCATCATTTCTAGATTCTAGAAGGCCCACTGCCAGCAAACACTGGTGACCTCTGTTTGCCTTTACAAGTACAACCTGATCGAGAGCAGGTTCGCTGGGCCCTTTTTA... |
Task1_train_10816 | The variant affects gene LTV1 (LTV1 ribosome biogenesis factor), which is on Chromosome 6. Please evaluate whether this mutation is benign or pathogenic and specify the disease if necessary. | Pathogenic; Inflammatory poikiloderma with hair abnormalities and acral keratoses | CTGAATACAGCACACTGATGGGTCTTGACTCTTTATCCAATTTGCCAATCTGTGTCTTTTAATTGGGGCTTTTATCCCATTTACATTTAAGGTTAATATTGTAATGTGTTATTTGATTCTGTCATTATGATGCTAGCTGGTTATTTTGCCCATTAGTTTATGCAGTTTCTTCTTAGTATCGATGGTCTTTACTGTTTGGTACGTTTTGCAGTGGCTGGTACCAGTTTTTCCTTTCCATATTTAGTGCTTCCTTCAGGAGCTCTTGTAAGGCAGGCCTGGTGGTGACAAAATCTCTCAGCATTTGCTTATCTGGAAAGGAT... | CTGAATACAGCACACTGATGGGTCTTGACTCTTTATCCAATTTGCCAATCTGTGTCTTTTAATTGGGGCTTTTATCCCATTTACATTTAAGGTTAATATTGTAATGTGTTATTTGATTCTGTCATTATGATGCTAGCTGGTTATTTTGCCCATTAGTTTATGCAGTTTCTTCTTAGTATCGATGGTCTTTACTGTTTGGTACGTTTTGCAGTGGCTGGTACCAGTTTTTCCTTTCCATATTTAGTGCTTCCTTCAGGAGCTCTTGTAAGGCAGGCCTGGTGGTGACAAAATCTCTCAGCATTTGCTTATCTGGAAAGGAT... |
Task1_train_10817 | This variant impacts the gene STX11 (syntaxin 11) on Chromosome 6. Is the change likely to result in a pathogenic outcome? | Pathogenic; Familial hemophagocytic lymphohistiocytosis 4 | AGAAAATATCAGGCATATATAACATACGTTTATGTTCTCTGTCATTTACATCTTCTCTGAATTGCTTCACTGTCTTTGGGTAAGTAGATTTTTTGGTAGCTTAGAAATATATATATTAAGTATCTTAACCTCTTGTCTGTCATATATTATAATTTCTCCCCAGTTGGTGGTTTGTCTTTCAATTTTGTTCAAAGTGAGGAAACAGTTGAATATCAAGAAATTCAGACCAGGTGAAGGCATAGTTTTGGTCCAGGGTGGATCTTTTTTCTGCCTGTCAACCATACTGCTAGGAGAATCACCTTCCCCATCCGTGAGAAGGT... | AGAAAATATCAGGCATATATAACATACGTTTATGTTCTCTGTCATTTACATCTTCTCTGAATTGCTTCACTGTCTTTGGGTAAGTAGATTTTTTGGTAGCTTAGAAATATATATATTAAGTATCTTAACCTCTTGTCTGTCATATATTATAATTTCTCCCCAGTTGGTGGTTTGTCTTTCAATTTTGTTCAAAGTGAGGAAACAGTTGAATATCAAGAAATTCAGACCAGGTGAAGGCATAGTTTTGGTCCAGGGTGGATCTTTTTTCTGCCTGTCAACCATACTGCTAGGAGAATCACCTTCCCCATCCGTGAGAAGGT... |
Task1_train_10818 | This sequence variant lies in STX11 (syntaxin 11) on Chromosome 6. Is it clinically significant, and what condition might it cause if any? | Pathogenic; Familial hemophagocytic lymphohistiocytosis | AGAAAATATCAGGCATATATAACATACGTTTATGTTCTCTGTCATTTACATCTTCTCTGAATTGCTTCACTGTCTTTGGGTAAGTAGATTTTTTGGTAGCTTAGAAATATATATATTAAGTATCTTAACCTCTTGTCTGTCATATATTATAATTTCTCCCCAGTTGGTGGTTTGTCTTTCAATTTTGTTCAAAGTGAGGAAACAGTTGAATATCAAGAAATTCAGACCAGGTGAAGGCATAGTTTTGGTCCAGGGTGGATCTTTTTTCTGCCTGTCAACCATACTGCTAGGAGAATCACCTTCCCCATCCGTGAGAAGGT... | AGAAAATATCAGGCATATATAACATACGTTTATGTTCTCTGTCATTTACATCTTCTCTGAATTGCTTCACTGTCTTTGGGTAAGTAGATTTTTTGGTAGCTTAGAAATATATATATTAAGTATCTTAACCTCTTGTCTGTCATATATTATAATTTCTCCCCAGTTGGTGGTTTGTCTTTCAATTTTGTTCAAAGTGAGGAAACAGTTGAATATCAAGAAATTCAGACCAGGTGAAGGCATAGTTTTGGTCCAGGGTGGATCTTTTTTCTGCCTGTCAACCATACTGCTAGGAGAATCACCTTCCCCATCCGTGAGAAGGT... |
Task1_train_10819 | Given this variant in gene EPM2A (EPM2A glucan phosphatase, laforin) on Chromosome 6, classify it as benign or pathogenic. Include the disorder it may cause if applicable. | Pathogenic; Lafora disease | ATGGAAATTATGAAGCTGGATTTCTTAGACATTAAAGAAATTCACAGACCCACATAGTTTAAAAATTTAATTTTTAAGATTAAATTTTCACAACACATTATGACTGTAAATGAGTTACCTGAATACCAATTATTACCTCTAGTTATTTTTAGCAAGGGAGCTGGACTTCACTTTACTTAATGCTAGCTTATAAATTTAACTTTGTAAAATTATAGTGGAAATGTGTCCTGGCTAGCTGCCTCTGCCCAAAGCAAATGTCATCTCCCCTAAGTGCCACAGTTCTATCTCCCCGTCCTCTGAGCTCCACTGAAACTTACCTT... | ATGGAAATTATGAAGCTGGATTTCTTAGACATTAAAGAAATTCACAGACCCACATAGTTTAAAAATTTAATTTTTAAGATTAAATTTTCACAACACATTATGACTGTAAATGAGTTACCTGAATACCAATTATTACCTCTAGTTATTTTTAGCAAGGGAGCTGGACTTCACTTTACTTAATGCTAGCTTATAAATTTAACTTTGTAAAATTATAGTGGAAATGTGTCCTGGCTAGCTGCCTCTGCCCAAAGCAAATGTCATCTCCCCTAAGTGCCACAGTTCTATCTCCCCGTCCTCTGAGCTCCACTGAAACTTACCTT... |
Task1_train_10820 | A genomic change on Chromosome 6 affects EPM2A (EPM2A glucan phosphatase, laforin). Classify this variant as benign or pathogenic, and name the disease if relevant. | Pathogenic; Progressive myoclonic epilepsy | ACAGACCCACATAGTTTAAAAATTTAATTTTTAAGATTAAATTTTCACAACACATTATGACTGTAAATGAGTTACCTGAATACCAATTATTACCTCTAGTTATTTTTAGCAAGGGAGCTGGACTTCACTTTACTTAATGCTAGCTTATAAATTTAACTTTGTAAAATTATAGTGGAAATGTGTCCTGGCTAGCTGCCTCTGCCCAAAGCAAATGTCATCTCCCCTAAGTGCCACAGTTCTATCTCCCCGTCCTCTGAGCTCCACTGAAACTTACCTTGTATCCTTCTTGTCCCCCACGCCTTCTAAATAAGAGTCTCTTG... | ACAGACCCACATAGTTTAAAAATTTAATTTTTAAGATTAAATTTTCACAACACATTATGACTGTAAATGAGTTACCTGAATACCAATTATTACCTCTAGTTATTTTTAGCAAGGGAGCTGGACTTCACTTTACTTAATGCTAGCTTATAAATTTAACTTTGTAAAATTATAGTGGAAATGTGTCCTGGCTAGCTGCCTCTGCCCAAAGCAAATGTCATCTCCCCTAAGTGCCACAGTTCTATCTCCCCGTCCTCTGAGCTCCACTGAAACTTACCTTGTATCCTTCTTGTCCCCCACGCCTTCTAAATAAGAGTCTCTTG... |
Task1_train_10821 | The gene EPM2A (EPM2A glucan phosphatase, laforin) on Chromosome 6 carries this variant. Does this mutation lead to a specific disease, or is it non-pathogenic? | Pathogenic; Lafora disease | ACAGACCCACATAGTTTAAAAATTTAATTTTTAAGATTAAATTTTCACAACACATTATGACTGTAAATGAGTTACCTGAATACCAATTATTACCTCTAGTTATTTTTAGCAAGGGAGCTGGACTTCACTTTACTTAATGCTAGCTTATAAATTTAACTTTGTAAAATTATAGTGGAAATGTGTCCTGGCTAGCTGCCTCTGCCCAAAGCAAATGTCATCTCCCCTAAGTGCCACAGTTCTATCTCCCCGTCCTCTGAGCTCCACTGAAACTTACCTTGTATCCTTCTTGTCCCCCACGCCTTCTAAATAAGAGTCTCTTG... | ACAGACCCACATAGTTTAAAAATTTAATTTTTAAGATTAAATTTTCACAACACATTATGACTGTAAATGAGTTACCTGAATACCAATTATTACCTCTAGTTATTTTTAGCAAGGGAGCTGGACTTCACTTTACTTAATGCTAGCTTATAAATTTAACTTTGTAAAATTATAGTGGAAATGTGTCCTGGCTAGCTGCCTCTGCCCAAAGCAAATGTCATCTCCCCTAAGTGCCACAGTTCTATCTCCCCGTCCTCTGAGCTCCACTGAAACTTACCTTGTATCCTTCTTGTCCCCCACGCCTTCTAAATAAGAGTCTCTTG... |
Task1_train_10822 | Gene EPM2A (EPM2A glucan phosphatase, laforin) on Chromosome 6 is altered by this variant. Does this mutation result in a disease or is it benign? | Pathogenic; Progressive myoclonic epilepsy | GAGCTGGACTTCACTTTACTTAATGCTAGCTTATAAATTTAACTTTGTAAAATTATAGTGGAAATGTGTCCTGGCTAGCTGCCTCTGCCCAAAGCAAATGTCATCTCCCCTAAGTGCCACAGTTCTATCTCCCCGTCCTCTGAGCTCCACTGAAACTTACCTTGTATCCTTCTTGTCCCCCACGCCTTCTAAATAAGAGTCTCTTGCATCTATCAATATGTGTTTGTGGAAGAAAGGAAGGTGCAGAAAAATAAATACGCATCATAGTTTAATTAGGAAAGTAAGGGCTTTGAATCAAACCCAGCTTTGTATCTCACTTC... | GAGCTGGACTTCACTTTACTTAATGCTAGCTTATAAATTTAACTTTGTAAAATTATAGTGGAAATGTGTCCTGGCTAGCTGCCTCTGCCCAAAGCAAATGTCATCTCCCCTAAGTGCCACAGTTCTATCTCCCCGTCCTCTGAGCTCCACTGAAACTTACCTTGTATCCTTCTTGTCCCCCACGCCTTCTAAATAAGAGTCTCTTGCATCTATCAATATGTGTTTGTGGAAGAAAGGAAGGTGCAGAAAAATAAATACGCATCATAGTTTAATTAGGAAAGTAAGGGCTTTGAATCAAACCCAGCTTTGTATCTCACTTC... |
Task1_train_10823 | The gene EPM2A (EPM2A glucan phosphatase, laforin), on Chromosome 6, contains a mutation. Does this mutation cause a disorder, or is it a benign change? | Pathogenic; Lafora disease | GAGCTGGACTTCACTTTACTTAATGCTAGCTTATAAATTTAACTTTGTAAAATTATAGTGGAAATGTGTCCTGGCTAGCTGCCTCTGCCCAAAGCAAATGTCATCTCCCCTAAGTGCCACAGTTCTATCTCCCCGTCCTCTGAGCTCCACTGAAACTTACCTTGTATCCTTCTTGTCCCCCACGCCTTCTAAATAAGAGTCTCTTGCATCTATCAATATGTGTTTGTGGAAGAAAGGAAGGTGCAGAAAAATAAATACGCATCATAGTTTAATTAGGAAAGTAAGGGCTTTGAATCAAACCCAGCTTTGTATCTCACTTC... | GAGCTGGACTTCACTTTACTTAATGCTAGCTTATAAATTTAACTTTGTAAAATTATAGTGGAAATGTGTCCTGGCTAGCTGCCTCTGCCCAAAGCAAATGTCATCTCCCCTAAGTGCCACAGTTCTATCTCCCCGTCCTCTGAGCTCCACTGAAACTTACCTTGTATCCTTCTTGTCCCCCACGCCTTCTAAATAAGAGTCTCTTGCATCTATCAATATGTGTTTGTGGAAGAAAGGAAGGTGCAGAAAAATAAATACGCATCATAGTTTAATTAGGAAAGTAAGGGCTTTGAATCAAACCCAGCTTTGTATCTCACTTC... |
Task1_train_10824 | Mutation context: Chromosome 6, Gene EPM2A (EPM2A glucan phosphatase, laforin). Determine if this variant is likely to be benign or pathogenic. Mention the disease if applicable. | Pathogenic; Inborn genetic diseases | GAGCTGGACTTCACTTTACTTAATGCTAGCTTATAAATTTAACTTTGTAAAATTATAGTGGAAATGTGTCCTGGCTAGCTGCCTCTGCCCAAAGCAAATGTCATCTCCCCTAAGTGCCACAGTTCTATCTCCCCGTCCTCTGAGCTCCACTGAAACTTACCTTGTATCCTTCTTGTCCCCCACGCCTTCTAAATAAGAGTCTCTTGCATCTATCAATATGTGTTTGTGGAAGAAAGGAAGGTGCAGAAAAATAAATACGCATCATAGTTTAATTAGGAAAGTAAGGGCTTTGAATCAAACCCAGCTTTGTATCTCACTTC... | GAGCTGGACTTCACTTTACTTAATGCTAGCTTATAAATTTAACTTTGTAAAATTATAGTGGAAATGTGTCCTGGCTAGCTGCCTCTGCCCAAAGCAAATGTCATCTCCCCTAAGTGCCACAGTTCTATCTCCCCGTCCTCTGAGCTCCACTGAAACTTACCTTGTATCCTTCTTGTCCCCCACGCCTTCTAAATAAGAGTCTCTTGCATCTATCAATATGTGTTTGTGGAAGAAAGGAAGGTGCAGAAAAATAAATACGCATCATAGTTTAATTAGGAAAGTAAGGGCTTTGAATCAAACCCAGCTTTGTATCTCACTTC... |
Task1_train_10825 | The gene EPM2A (EPM2A glucan phosphatase, laforin) is located on Chromosome 6, where a mutation has occurred. What is the medical relevance of this mutation? | Pathogenic; Lafora disease | TGACAAATATAAAATGTAAATCCAAGAGGTCCAACATCCATCTAAGGAGTGTCTCTAATGACAAAGAGCAAAGGCAATCAAGGAGAAGAAATAATCATTCAGTGGAAAAAAATCTCCAGAGCCCAAGATATGACTCTTCAGAAAAAAGGGTTCATTCAGGAAATGTGGTTCAGGATCATTTAAAAGAACCCATAAACATATCCTCATTAAATGTCAGACCATCTCAAGAAGTGTTGCTTCTCATTCCTTTCTCTGGATCTTCTGCTTCTCCTTGACTTCTAAATTGTGTGAACCAGGGCTCAATATTTTTGCTTCTTCTC... | TGACAAATATAAAATGTAAATCCAAGAGGTCCAACATCCATCTAAGGAGTGTCTCTAATGACAAAGAGCAAAGGCAATCAAGGAGAAGAAATAATCATTCAGTGGAAAAAAATCTCCAGAGCCCAAGATATGACTCTTCAGAAAAAAGGGTTCATTCAGGAAATGTGGTTCAGGATCATTTAAAAGAACCCATAAACATATCCTCATTAAATGTCAGACCATCTCAAGAAGTGTTGCTTCTCATTCCTTTCTCTGGATCTTCTGCTTCTCCTTGACTTCTAAATTGTGTGAACCAGGGCTCAATATTTTTGCTTCTTCTC... |
Task1_train_10826 | Here’s a variant in EPM2A (EPM2A glucan phosphatase, laforin) located on Chromosome 6. What is the predicted biological effect — harmless or disease-causing? | Pathogenic; Progressive myoclonic epilepsy | TGACAAATATAAAATGTAAATCCAAGAGGTCCAACATCCATCTAAGGAGTGTCTCTAATGACAAAGAGCAAAGGCAATCAAGGAGAAGAAATAATCATTCAGTGGAAAAAAATCTCCAGAGCCCAAGATATGACTCTTCAGAAAAAAGGGTTCATTCAGGAAATGTGGTTCAGGATCATTTAAAAGAACCCATAAACATATCCTCATTAAATGTCAGACCATCTCAAGAAGTGTTGCTTCTCATTCCTTTCTCTGGATCTTCTGCTTCTCCTTGACTTCTAAATTGTGTGAACCAGGGCTCAATATTTTTGCTTCTTCTC... | TGACAAATATAAAATGTAAATCCAAGAGGTCCAACATCCATCTAAGGAGTGTCTCTAATGACAAAGAGCAAAGGCAATCAAGGAGAAGAAATAATCATTCAGTGGAAAAAAATCTCCAGAGCCCAAGATATGACTCTTCAGAAAAAAGGGTTCATTCAGGAAATGTGGTTCAGGATCATTTAAAAGAACCCATAAACATATCCTCATTAAATGTCAGACCATCTCAAGAAGTGTTGCTTCTCATTCCTTTCTCTGGATCTTCTGCTTCTCCTTGACTTCTAAATTGTGTGAACCAGGGCTCAATATTTTTGCTTCTTCTC... |
Task1_train_10827 | The following genetic variant occurs in EPM2A (EPM2A glucan phosphatase, laforin) on Chromosome 6. Classify its clinical effect — pathogenic or benign — and list any associated condition. | Pathogenic; Self-limited epilepsy with centrotemporal spikes | ATAAAATGTAAATCCAAGAGGTCCAACATCCATCTAAGGAGTGTCTCTAATGACAAAGAGCAAAGGCAATCAAGGAGAAGAAATAATCATTCAGTGGAAAAAAATCTCCAGAGCCCAAGATATGACTCTTCAGAAAAAAGGGTTCATTCAGGAAATGTGGTTCAGGATCATTTAAAAGAACCCATAAACATATCCTCATTAAATGTCAGACCATCTCAAGAAGTGTTGCTTCTCATTCCTTTCTCTGGATCTTCTGCTTCTCCTTGACTTCTAAATTGTGTGAACCAGGGCTCAATATTTTTGCTTCTTCTCTTTGTCTC... | ATAAAATGTAAATCCAAGAGGTCCAACATCCATCTAAGGAGTGTCTCTAATGACAAAGAGCAAAGGCAATCAAGGAGAAGAAATAATCATTCAGTGGAAAAAAATCTCCAGAGCCCAAGATATGACTCTTCAGAAAAAAGGGTTCATTCAGGAAATGTGGTTCAGGATCATTTAAAAGAACCCATAAACATATCCTCATTAAATGTCAGACCATCTCAAGAAGTGTTGCTTCTCATTCCTTTCTCTGGATCTTCTGCTTCTCCTTGACTTCTAAATTGTGTGAACCAGGGCTCAATATTTTTGCTTCTTCTCTTTGTCTC... |
Task1_train_10828 | This variant impacts the gene EPM2A, EPM2A-DT, LOC129997381 (EPM2A glucan phosphatase, laforin| EPM2A divergent transcript| ATAC-STARR-seq lymphoblastoid silent region 17642) on Chromosome 6. Is the change likely to result in a pathogenic outcome? | Pathogenic; Progressive myoclonic epilepsy | TATAGGAGTAACTTCCTAGAAAGTCAACAGTCAATTTTTAATACAAAACTGAAAATAATTCCTGCTTGGATAGTAAAGAAAAATATTTATCAAAAAAACTGAAAATAATAGTAAAAAAAAATCAGCAGGGAAGACAGAGAGTGAACTTGAGCTAAATTCCTCATATTTCATAACAAGTGTGATGGTTAATTTTATGAGCATCCAGTAGGTGTCAATATCTATTGCCTAATTTTAACTTTTAAAATTATATATAACTTATATGGTAACTATTAGAAAAATTAAAAACAAAAGTTTGTGGTACCTTAAGAAATAGCAACATA... | TATAGGAGTAACTTCCTAGAAAGTCAACAGTCAATTTTTAATACAAAACTGAAAATAATTCCTGCTTGGATAGTAAAGAAAAATATTTATCAAAAAAACTGAAAATAATAGTAAAAAAAAATCAGCAGGGAAGACAGAGAGTGAACTTGAGCTAAATTCCTCATATTTCATAACAAGTGTGATGGTTAATTTTATGAGCATCCAGTAGGTGTCAATATCTATTGCCTAATTTTAACTTTTAAAATTATATATAACTTATATGGTAACTATTAGAAAAATTAAAAACAAAAGTTTGTGGTACCTTAAGAAATAGCAACATA... |
Task1_train_10829 | Located on Chromosome 6, this mutation impacts GRM1 (glutamate metabotropic receptor 1). What is its biological consequence — is it benign or pathogenic, and which disease is associated if any? | Pathogenic; Spinocerebellar ataxia 44 | AAGAGAAGATTATGAGGTAATGGGTATGCCTATGTCCAAACTCATCAAGACGTATACATTAAATGTGTACAGTTTTTGTATATCAATTAGAAGTCAACTAAGACAAAGAGAAAAAAATGCTAAAAAGGAAAGAATAGAAGAAGCAAATACATTGACCTAGGCAACTATTGTTGCTATAAACAGGAGCAATGAATGAGTAACTCAAGAGGGACAATGAGGTCAGGGGTATTTTTCTTTTTGATTGACACTGATAGGAAGGAGAAATTGATTATCCAAGAGAGGGAACAACTGTAGGAGAAACTCCTTGAATAGACAAAAAG... | AAGAGAAGATTATGAGGTAATGGGTATGCCTATGTCCAAACTCATCAAGACGTATACATTAAATGTGTACAGTTTTTGTATATCAATTAGAAGTCAACTAAGACAAAGAGAAAAAAATGCTAAAAAGGAAAGAATAGAAGAAGCAAATACATTGACCTAGGCAACTATTGTTGCTATAAACAGGAGCAATGAATGAGTAACTCAAGAGGGACAATGAGGTCAGGGGTATTTTTCTTTTTGATTGACACTGATAGGAAGGAGAAATTGATTATCCAAGAGAGGGAACAACTGTAGGAGAAACTCCTTGAATAGACAAAAAG... |
Task1_train_10830 | This is a variant in GRM1 (glutamate metabotropic receptor 1), located on Chromosome 6. Is this mutation a likely cause of disease or not? | Pathogenic; Autosomal recessive spinocerebellar ataxia 13 | GTAATGACTGCAACTTTGGGTGATGGTTTTAGTATTGACAGGACACTTTAAGGGGCTGCTGTCTTCAAGGTTATTTTGCCACTCAATTTTTGTGTTTTTTTTTTTCTTTAACTCTTGGTAATTTCTATGATTCTAGTAGCTTTAATATTTAGCATTTGGGGTTCTAGGCGAGCCTATAAGGGCTTGTTTAAGAGTTATCAGGCAGATGGCACAAATTTACCTCTTTTATGGTCCCAGTAAGTTGGAGAGGGAGAGAAAGAAAACCAACAGTAAGGGCCATGGGTTCTGAGTGACAGACATAAGCTACTCTGTTTAAATGA... | GTAATGACTGCAACTTTGGGTGATGGTTTTAGTATTGACAGGACACTTTAAGGGGCTGCTGTCTTCAAGGTTATTTTGCCACTCAATTTTTGTGTTTTTTTTTTTCTTTAACTCTTGGTAATTTCTATGATTCTAGTAGCTTTAATATTTAGCATTTGGGGTTCTAGGCGAGCCTATAAGGGCTTGTTTAAGAGTTATCAGGCAGATGGCACAAATTTACCTCTTTTATGGTCCCAGTAAGTTGGAGAGGGAGAGAAAGAAAACCAACAGTAAGGGCCATGGGTTCTGAGTGACAGACATAAGCTACTCTGTTTAAATGA... |
Task1_train_10831 | This variant impacts the gene GRM1 (glutamate metabotropic receptor 1) on Chromosome 6. Is the change likely to result in a pathogenic outcome? | Pathogenic; Cerebellar ataxia | AGACCCCGTCTCAAAAAAAAAAGAAAAAAAAAAAAAAAAAAAAAGCACAAAAGCTAAACAAATTGCTTACTATAGTAAGGGATAGTTATGCTAGGCAGATACATTTTCTCTGAGCAGAAGACTATTCATTTTATATGGAGTTTTTAGAAAGTGTGGAGTTTAGGGATTGAAAACCTTGCAGCTTCTGAGAGCTGGTTGACATCACCTGTAGCAATACGATTACTCACATGAGACTGTTGATTAGTTGGCACTCATTTATTGAAGTGATTCTGATCCTGCCTGAGTGATTATCAGAAGTAAGGGCTGACAGTGCTTGCTTG... | AGACCCCGTCTCAAAAAAAAAAGAAAAAAAAAAAAAAAAAAAAAGCACAAAAGCTAAACAAATTGCTTACTATAGTAAGGGATAGTTATGCTAGGCAGATACATTTTCTCTGAGCAGAAGACTATTCATTTTATATGGAGTTTTTAGAAAGTGTGGAGTTTAGGGATTGAAAACCTTGCAGCTTCTGAGAGCTGGTTGACATCACCTGTAGCAATACGATTACTCACATGAGACTGTTGATTAGTTGGCACTCATTTATTGAAGTGATTCTGATCCTGCCTGAGTGATTATCAGAAGTAAGGGCTGACAGTGCTTGCTTG... |
Task1_train_10832 | Given this context: Chromosome 6, gene TAB2 (TGF-beta activated kinase 1 (MAP3K7) binding protein 2) — does this variant present pathogenic behavior, and if so, what disease does it relate to? | Pathogenic; Congenital heart defects, multiple types, 2 | TTAACTCTCACCTTTATATTCTTCTTTACTCGTGCCATTCTCTTCACCAAGAATTGTTGTTGTTGTCGTTGTTGTTGTTCAAGTTCTACATATTCTATGAAAACCATCAGGCCATACCTTCCTCATTAACTCAGTCCTTTCTTCGGTAGCCTACAATATTAATTCTCTATTGAACTTCATTACCACTTAATATTTGGCATGTACTCATGTTACCTTTTCAGAAATCTGTGGTTTGTCTCCCTTTCTAGGGGAAAAGTTTGGTTTTATATGTCTTTGATTCTTCCACAGGCTCACAGTGCTATGCATATAGTATGTGTTTG... | TTAACTCTCACCTTTATATTCTTCTTTACTCGTGCCATTCTCTTCACCAAGAATTGTTGTTGTTGTCGTTGTTGTTGTTCAAGTTCTACATATTCTATGAAAACCATCAGGCCATACCTTCCTCATTAACTCAGTCCTTTCTTCGGTAGCCTACAATATTAATTCTCTATTGAACTTCATTACCACTTAATATTTGGCATGTACTCATGTTACCTTTTCAGAAATCTGTGGTTTGTCTCCCTTTCTAGGGGAAAAGTTTGGTTTTATATGTCTTTGATTCTTCCACAGGCTCACAGTGCTATGCATATAGTATGTGTTTG... |
Task1_train_10833 | The gene LATS1 (large tumor suppressor kinase 1) on Chromosome 6 carries this variant. Does this mutation lead to a specific disease, or is it non-pathogenic? | Pathogenic; Myoepithelial tumor | CAGCTACTCTGGAGGCTGACGCTGGAGAACTGCTTGAACCCGGGAGGCGGAGGTTGGGAGGTGGAGGTTGCAGTAAGCCAAGATTGTGCCACTGCACTCCAGCCTGGGTGACAAGACTCTGTCTCAAAGAGAAAAAAAAAAAAAAATTAAAAGAGGTAAAGTGGCAATGAAAAATAACCAATAGGCCAGGCGCGGTGGCTCATACCTGTAATCCCAGCACTTTGGGAGGCCAAGGCAGGCAGATCACGAGGTCAGGAGTTCAAGACCAGCATGGCCAAGATGGTGAAACCCCATCTCTACTAAAAATACAAAAATTAGCT... | CAGCTACTCTGGAGGCTGACGCTGGAGAACTGCTTGAACCCGGGAGGCGGAGGTTGGGAGGTGGAGGTTGCAGTAAGCCAAGATTGTGCCACTGCACTCCAGCCTGGGTGACAAGACTCTGTCTCAAAGAGAAAAAAAAAAAAAAATTAAAAGAGGTAAAGTGGCAATGAAAAATAACCAATAGGCCAGGCGCGGTGGCTCATACCTGTAATCCCAGCACTTTGGGAGGCCAAGGCAGGCAGATCACGAGGTCAGGAGTTCAAGACCAGCATGGCCAAGATGGTGAAACCCCATCTCTACTAAAAATACAAAAATTAGCT... |
Task1_train_10834 | The gene IYD (iodotyrosine deiodinase) on Chromosome 6 contains a mutation. Based on this information, is the variant pathogenic or benign? Provide the disease if relevant. | Pathogenic; Iodotyrosine deiodination defect | TGTAGATCTGGTATTTTTCATGAGTTCTGCAAAAATCTCAGATGCTATCTTTTCAAATATTGCCTCCACCATATACTCTTTGAATCAAATGATCAAATGTATATTAGACATTCTCACTCTTCACTCTGCTCTATTTTTTCTTGCCCTTTCCTCTATATTTTCTATCTTTTTGTCTCTCCTTGCCCAATTCTAAGTGTTTTCTTCTGACTTACCTCCCAGTTCATTAATTTTTCTGTAGCTAGTGTAACCTGCTAGTCAACCATCCTTTTAAGTTCTTAATTCTATTATTTTTCAATTCCAGAAGTTCTCTATTTTTTCAG... | TGTAGATCTGGTATTTTTCATGAGTTCTGCAAAAATCTCAGATGCTATCTTTTCAAATATTGCCTCCACCATATACTCTTTGAATCAAATGATCAAATGTATATTAGACATTCTCACTCTTCACTCTGCTCTATTTTTTCTTGCCCTTTCCTCTATATTTTCTATCTTTTTGTCTCTCCTTGCCCAATTCTAAGTGTTTTCTTCTGACTTACCTCCCAGTTCATTAATTTTTCTGTAGCTAGTGTAACCTGCTAGTCAACCATCCTTTTAAGTTCTTAATTCTATTATTTTTCAATTCCAGAAGTTCTCTATTTTTTCAG... |
Task1_train_10835 | A mutation found in RMND1 (required for meiotic nuclear division 1 homolog) on Chromosome 6 may be clinically relevant. Is it pathogenic or benign, and if the former, which disease is implicated? | Pathogenic; Mitochondrial disease | AGTTTTTGTGGGTACCCTTGGCATACAGGTAGGTACCTCAAATGGAAGACAGCTACTGAAGAACTCTCGCTGGAAGACATCAGATGTTTATCCTAGCACTGTTAACTGCAGATAAATATGTCCATCAGTTAGTACAGATGAATGTATTCTCTTGGTATAATACTGTGTAGCAGTTAAGTGAGTTGCAAAACGAAAGGATATGTGTGAAAAAAAAGTTGACAGGTGAGGACTATAGTGGGGCATCGGGTTATGCATAAAAGTAAGGCAATGAAGGTAAAGATTTGATTTTTAAATGTTGTCAACCCAAGGAGGTAAATATG... | AGTTTTTGTGGGTACCCTTGGCATACAGGTAGGTACCTCAAATGGAAGACAGCTACTGAAGAACTCTCGCTGGAAGACATCAGATGTTTATCCTAGCACTGTTAACTGCAGATAAATATGTCCATCAGTTAGTACAGATGAATGTATTCTCTTGGTATAATACTGTGTAGCAGTTAAGTGAGTTGCAAAACGAAAGGATATGTGTGAAAAAAAAGTTGACAGGTGAGGACTATAGTGGGGCATCGGGTTATGCATAAAAGTAAGGCAATGAAGGTAAAGATTTGATTTTTAAATGTTGTCAACCCAAGGAGGTAAATATG... |
Task1_train_10836 | This mutation occurs in RMND1 (required for meiotic nuclear division 1 homolog) on Chromosome 6. Does this change lead to a known medical condition, or is it benign? | Pathogenic; Combined oxidative phosphorylation defect type 11 | TACTGAAGAACTCTCGCTGGAAGACATCAGATGTTTATCCTAGCACTGTTAACTGCAGATAAATATGTCCATCAGTTAGTACAGATGAATGTATTCTCTTGGTATAATACTGTGTAGCAGTTAAGTGAGTTGCAAAACGAAAGGATATGTGTGAAAAAAAAGTTGACAGGTGAGGACTATAGTGGGGCATCGGGTTATGCATAAAAGTAAGGCAATGAAGGTAAAGATTTGATTTTTAAATGTTGTCAACCCAAGGAGGTAAATATGTAGATGTTAAATTCTTTGTGCTTGGTATTTTTTAAATTTCCCCAAAATATCTC... | TACTGAAGAACTCTCGCTGGAAGACATCAGATGTTTATCCTAGCACTGTTAACTGCAGATAAATATGTCCATCAGTTAGTACAGATGAATGTATTCTCTTGGTATAATACTGTGTAGCAGTTAAGTGAGTTGCAAAACGAAAGGATATGTGTGAAAAAAAAGTTGACAGGTGAGGACTATAGTGGGGCATCGGGTTATGCATAAAAGTAAGGCAATGAAGGTAAAGATTTGATTTTTAAATGTTGTCAACCCAAGGAGGTAAATATGTAGATGTTAAATTCTTTGTGCTTGGTATTTTTTAAATTTCCCCAAAATATCTC... |
Task1_train_10837 | This variant affects the gene RMND1 (required for meiotic nuclear division 1 homolog) found on Chromosome 6. What is the clinical effect of this variant — benign or pathogenic? State the disease if applicable. | Pathogenic; Combined oxidative phosphorylation defect type 11 | ACACACAGGCTCAGAGAGGAGGTGGGACGGAGCAGAGCAGCATCTCAGAATAAACAGCCAGTAGCTGCGTGGCTGCAGATGTGGTCAAGCAGTGGGCAAGCAGGATAAAGAGGCAAGCAGGGGACAATCCAGAAGGGAACTTTATGCAGTGATAGAGAATTTGTTCATAGTCCGTGGAAATTTAGGCAGGAGAGTGTAGTGGTCAGAAATGGCCACTGAAGAATGACCCTGCTTACAATAGACAAACAGACTGGTGGTGGGTGAGCAGGCAGGCAGGGAGACAATAAGCTGTTACAATAGGCAGGGATAAGGTTTCAGGA... | ACACACAGGCTCAGAGAGGAGGTGGGACGGAGCAGAGCAGCATCTCAGAATAAACAGCCAGTAGCTGCGTGGCTGCAGATGTGGTCAAGCAGTGGGCAAGCAGGATAAAGAGGCAAGCAGGGGACAATCCAGAAGGGAACTTTATGCAGTGATAGAGAATTTGTTCATAGTCCGTGGAAATTTAGGCAGGAGAGTGTAGTGGTCAGAAATGGCCACTGAAGAATGACCCTGCTTACAATAGACAAACAGACTGGTGGTGGGTGAGCAGGCAGGCAGGGAGACAATAAGCTGTTACAATAGGCAGGGATAAGGTTTCAGGA... |
Task1_train_10838 | Located on Chromosome 6, this mutation impacts RMND1 (required for meiotic nuclear division 1 homolog). What is its biological consequence — is it benign or pathogenic, and which disease is associated if any? | Pathogenic; Combined oxidative phosphorylation defect type 11 | CCAAAACTGTGATTTTTTTTTTTTTTCTAAATTGTTAATTACTACATCCTACATAGGACAGAGTTTGCCTACACAGCCAAAAGCAAAATAAAATCGACTGAAACAACCCAGGGCAGTGAAGCCTGCAATTCTGTGAAGCACAGACCACACAGCTGGCAGCCTTCAGCATCAGCCAACAATACCTCCAGGCAAATTTTCATACCAAGGGGCTCTAGACATAGCTCTGTCTTTCTAAGTCAACTATGCTTGTTTTTGTCACCTAATCACACAAACGGTCTGTTTGGATTATCACAATGATATTTCAACTATCTTCTATGGGA... | CCAAAACTGTGATTTTTTTTTTTTTTCTAAATTGTTAATTACTACATCCTACATAGGACAGAGTTTGCCTACACAGCCAAAAGCAAAATAAAATCGACTGAAACAACCCAGGGCAGTGAAGCCTGCAATTCTGTGAAGCACAGACCACACAGCTGGCAGCCTTCAGCATCAGCCAACAATACCTCCAGGCAAATTTTCATACCAAGGGGCTCTAGACATAGCTCTGTCTTTCTAAGTCAACTATGCTTGTTTTTGTCACCTAATCACACAAACGGTCTGTTTGGATTATCACAATGATATTTCAACTATCTTCTATGGGA... |
Task1_train_10839 | A mutation in RMND1 (required for meiotic nuclear division 1 homolog), located on Chromosome 6, is being studied. Determine whether it’s pathogenic or benign, and specify the linked disease. | Pathogenic; Mitochondrial disease | AAGCAAAATAAAATCGACTGAAACAACCCAGGGCAGTGAAGCCTGCAATTCTGTGAAGCACAGACCACACAGCTGGCAGCCTTCAGCATCAGCCAACAATACCTCCAGGCAAATTTTCATACCAAGGGGCTCTAGACATAGCTCTGTCTTTCTAAGTCAACTATGCTTGTTTTTGTCACCTAATCACACAAACGGTCTGTTTGGATTATCACAATGATATTTCAACTATCTTCTATGGGATTGAGTCTTAAGAATTTCCACTGTTATAGGAAGGCTTTCAACCTATTTTTGCTACTCTTAGGTAAATTAATAAATGTTCT... | AAGCAAAATAAAATCGACTGAAACAACCCAGGGCAGTGAAGCCTGCAATTCTGTGAAGCACAGACCACACAGCTGGCAGCCTTCAGCATCAGCCAACAATACCTCCAGGCAAATTTTCATACCAAGGGGCTCTAGACATAGCTCTGTCTTTCTAAGTCAACTATGCTTGTTTTTGTCACCTAATCACACAAACGGTCTGTTTGGATTATCACAATGATATTTCAACTATCTTCTATGGGATTGAGTCTTAAGAATTTCCACTGTTATAGGAAGGCTTTCAACCTATTTTTGCTACTCTTAGGTAAATTAATAAATGTTCT... |
Task1_train_10840 | A variant on Chromosome 6 in gene ESR1 (estrogen receptor 1) has been observed. Is this a neutral mutation, or does it result in a disease? If so, which one? | Pathogenic; Estrogen resistance syndrome | TAAACATTACAACTACTTTGAAAACAGTTTGACAGTTTCTTAAAAAGCTAAAACATCCACCTGGCATGCTATATACAGATATCCTACTCTTACGTATTTAACCAAGAGAAATAAAAGCATATATCCATTCAAAAACTTGTAAATAAATTGCTCCTAGCAGCTTTATTTGTAATAGCCAAAAACTAGAAACAACCCAAATGTCCAATGAAAGGATACATCGTATTTATTTATAGGACATATCCATGCAATGGAATACCACTTAGGAATAGAAAGAATCAACTGTTCATCATACATACAACCACATGGCTAAGTCTTAAAAA... | TAAACATTACAACTACTTTGAAAACAGTTTGACAGTTTCTTAAAAAGCTAAAACATCCACCTGGCATGCTATATACAGATATCCTACTCTTACGTATTTAACCAAGAGAAATAAAAGCATATATCCATTCAAAAACTTGTAAATAAATTGCTCCTAGCAGCTTTATTTGTAATAGCCAAAAACTAGAAACAACCCAAATGTCCAATGAAAGGATACATCGTATTTATTTATAGGACATATCCATGCAATGGAATACCACTTAGGAATAGAAAGAATCAACTGTTCATCATACATACAACCACATGGCTAAGTCTTAAAAA... |
Task1_train_10841 | A genomic change on Chromosome 6 affects ARID1B (AT-rich interaction domain 1B). Classify this variant as benign or pathogenic, and name the disease if relevant. | Pathogenic; Coffin-Siris syndrome 1 | TCCTTTTTCTTGTTTTCACCCTTGCTGCTTTACTGCACACACACACACATGCATACCCATACGTGCACGTGCATGCACACACACACACATACCCATGTAGATGTGAGCTTCTCGAGTGCAAGAACTGGATTGTATTTAGCTTTACGTCACCTGTGCCTAGAACAGCTTCTGGAATGTAGTAAGTGTATAGTTATGTTACATGGATGGAGAAAGGCTTCCAAAAAATAGTAAGGACTGATTGGGAAACACTAATCCATATTCCACACACACTTGTCTTTCGCATTTATGTAATTTCAACATTCAGTTATCAGGAGGCAGCA... | TCCTTTTTCTTGTTTTCACCCTTGCTGCTTTACTGCACACACACACACATGCATACCCATACGTGCACGTGCATGCACACACACACACATACCCATGTAGATGTGAGCTTCTCGAGTGCAAGAACTGGATTGTATTTAGCTTTACGTCACCTGTGCCTAGAACAGCTTCTGGAATGTAGTAAGTGTATAGTTATGTTACATGGATGGAGAAAGGCTTCCAAAAAATAGTAAGGACTGATTGGGAAACACTAATCCATATTCCACACACACTTGTCTTTCGCATTTATGTAATTTCAACATTCAGTTATCAGGAGGCAGCA... |
Task1_train_10842 | Consider a variant on Chromosome 6 in gene ARID1B (AT-rich interaction domain 1B). Determine its clinical classification and disease relevance. | Pathogenic; Coffin-Siris syndrome 1 | CCGCTCTGAATCAACTAGCCAGGACATGTGGACTCGCATACATAAGCCCCTCTTTTCGCACTCATCCTGCTCTTTTATCCTTCTATTCTTCTGAAAAGGGTGTTTTTTAATGTACAGGTTTACTAATTCATATCTCGTTAGACCCCAGAGACAAAACTGCGTGGAAGCAGTCCAGTCCACTGCTTTGAACAAGGCGGTCTTCGCGGTGTAATATCTCTCAGCTGCTTGAGGTTTCACACATTCACAAAAATAACAGCATTTTTAGCTGATCCCAATAGATTTTTCTCTGCAGCTGCATCACTTGAAAAAGCTTTTTGTTC... | CCGCTCTGAATCAACTAGCCAGGACATGTGGACTCGCATACATAAGCCCCTCTTTTCGCACTCATCCTGCTCTTTTATCCTTCTATTCTTCTGAAAAGGGTGTTTTTTAATGTACAGGTTTACTAATTCATATCTCGTTAGACCCCAGAGACAAAACTGCGTGGAAGCAGTCCAGTCCACTGCTTTGAACAAGGCGGTCTTCGCGGTGTAATATCTCTCAGCTGCTTGAGGTTTCACACATTCACAAAAATAACAGCATTTTTAGCTGATCCCAATAGATTTTTCTCTGCAGCTGCATCACTTGAAAAAGCTTTTTGTTC... |
Task1_train_10843 | This sequence change occurs on Chromosome 6, altering SERAC1 (serine active site containing 1). What is the medical significance of this variant — is it benign or linked to a disease? | Pathogenic; 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome | GAAATGGGGAGGGAGACCTGGGGTCTTGCCTGCTCACCTTGACACCCTTCTTGGGCACCTACGGGAGGTTCATTCAGAAAGCAGTTTGATAACACTGATTTAGACCAACTCTGTCAATCTGTAGACAAAGCTTCCCGGAAAAGTTAACTGACTGGTCTAAGACTGCACAGCAAATCAAAGGTAGGATCCGGCTACTCTCAGTCCAGTAACTCTGAAATCCAGCACTCCTTCCCATGTATACAACTGGCACAGATGACATACAAGGGAAATAGCAGCTGATATTTCTCAGCATCTTTCTCTTTGCTTCCTTTAGCCAGTAT... | GAAATGGGGAGGGAGACCTGGGGTCTTGCCTGCTCACCTTGACACCCTTCTTGGGCACCTACGGGAGGTTCATTCAGAAAGCAGTTTGATAACACTGATTTAGACCAACTCTGTCAATCTGTAGACAAAGCTTCCCGGAAAAGTTAACTGACTGGTCTAAGACTGCACAGCAAATCAAAGGTAGGATCCGGCTACTCTCAGTCCAGTAACTCTGAAATCCAGCACTCCTTCCCATGTATACAACTGGCACAGATGACATACAAGGGAAATAGCAGCTGATATTTCTCAGCATCTTTCTCTTTGCTTCCTTTAGCCAGTAT... |
Task1_train_10844 | This alteration occurs within gene GTF2H5 (general transcription factor IIH subunit 5) located on Chromosome 6. Is it associated with a disease or is it a benign variant? | Pathogenic; Trichothiodystrophy 3, photosensitive | CCAGAAGCCTGTCCACCGGGTGCTGGGGGCACAGGGCGGTGTCCCCCACTCTCTCCGGGCCCTTCCTGGCGGGGCCGCACGGCAGTCCCCCCCTCGTTTAATCGTGGGTTTCCTGTGGGGCTAGGGCTCGCCCTGCGCCCAGGTGTAAGTGGAAGTTAATTAAATGGGCGTACGCTGAGTGGTTTGTTTCCAGCCTAGGTCCGCACGGGACGTGATTTATTTAGTGAAGGGGCACAAGATCTGGAGATCTGGCTTGTACTTTTTTCCTTTGGCCAGGAACTACGGCTTAATCTCTTCCTTTGGTCTCCTCATATGTAAAA... | CCAGAAGCCTGTCCACCGGGTGCTGGGGGCACAGGGCGGTGTCCCCCACTCTCTCCGGGCCCTTCCTGGCGGGGCCGCACGGCAGTCCCCCCCTCGTTTAATCGTGGGTTTCCTGTGGGGCTAGGGCTCGCCCTGCGCCCAGGTGTAAGTGGAAGTTAATTAAATGGGCGTACGCTGAGTGGTTTGTTTCCAGCCTAGGTCCGCACGGGACGTGATTTATTTAGTGAAGGGGCACAAGATCTGGAGATCTGGCTTGTACTTTTTTCCTTTGGCCAGGAACTACGGCTTAATCTCTTCCTTTGGTCTCCTCATATGTAAAA... |
Task1_train_10845 | This is a variant in GTF2H5 (general transcription factor IIH subunit 5), located on Chromosome 6. Is this mutation a likely cause of disease or not? | Pathogenic; Trichothiodystrophy 3, photosensitive | TCACATCGCTTTCAGGACTCTTTGGGTTTTCTTTCTACCTCGGTGGTCACTTCTTACTCAGCTTCTTCACTCAGGGGCCAGTAGGCATCTCAAAATATAACATCAAAAACTAAACCTTTTTTTTTTTTAGTAGAGTCAGGGTCTCACTGTGCTGTCCAGGCTAGTCTCTAACTCCTGACCTCAAGCAGTCCTCCAGCCTAGGCCTCTCGAAGTGCTGGGATTACAGCATGAGCCACCATGCCCACCCTAAAACCAAACTTGATCTTACCTGCAGATCTTACACATTCCTCTTTATCTCAGTAAAAATCTCCTCCAGTCTT... | TCACATCGCTTTCAGGACTCTTTGGGTTTTCTTTCTACCTCGGTGGTCACTTCTTACTCAGCTTCTTCACTCAGGGGCCAGTAGGCATCTCAAAATATAACATCAAAAACTAAACCTTTTTTTTTTTTAGTAGAGTCAGGGTCTCACTGTGCTGTCCAGGCTAGTCTCTAACTCCTGACCTCAAGCAGTCCTCCAGCCTAGGCCTCTCGAAGTGCTGGGATTACAGCATGAGCCACCATGCCCACCCTAAAACCAAACTTGATCTTACCTGCAGATCTTACACATTCCTCTTTATCTCAGTAAAAATCTCCTCCAGTCTT... |
Task1_train_10846 | Gene PNLDC1 (PARN like ribonuclease domain containing exonuclease 1) on Chromosome 6 is altered by this variant. Does this mutation result in a disease or is it benign? | Pathogenic; Spermatogenic failure 57 | GAATCAAATGGCTTAATAGTCCCCTTTTGCTTAATTAATGTCCCGGAGAGGCATTTAAAAGTATAATTGAAGATCGGATGCAGTGCCTCACACCTCTAATCCCACCACTTTAGGAGGCTGAAGCAGGTGGATCACTTGAGGCCAGGAATTCGAGACCAGCCTGGCCAATACGGTTTAACCCTATCTCTACTAAAAACAAAAATGAGTTGGGCGTGGTGGTGCATGCCTGTAATCCCAGCTGTTCAGAGGCTGAGGCGGGAGAATCGCTTGAACTCAGGAGGTGGAGATTGCAGAGAGCCGAGATGGCACCACTGCACTCC... | GAATCAAATGGCTTAATAGTCCCCTTTTGCTTAATTAATGTCCCGGAGAGGCATTTAAAAGTATAATTGAAGATCGGATGCAGTGCCTCACACCTCTAATCCCACCACTTTAGGAGGCTGAAGCAGGTGGATCACTTGAGGCCAGGAATTCGAGACCAGCCTGGCCAATACGGTTTAACCCTATCTCTACTAAAAACAAAAATGAGTTGGGCGTGGTGGTGCATGCCTGTAATCCCAGCTGTTCAGAGGCTGAGGCGGGAGAATCGCTTGAACTCAGGAGGTGGAGATTGCAGAGAGCCGAGATGGCACCACTGCACTCC... |
Task1_train_10847 | Given this variant in gene PNLDC1 (PARN like ribonuclease domain containing exonuclease 1) on Chromosome 6, classify it as benign or pathogenic. Include the disorder it may cause if applicable. | Pathogenic; Male infertility with azoospermia or oligozoospermia due to single gene mutation | GATGTGGGCTCACCGCAACCTCCACCACCCAGGTTCGGGTGATTCTCCTGCCTCAGCCTCCAGAGCAGCTGGGATTACAGGCAATTGCCACCAGGCCTGGCTAATTTTTGTATTTTTAGTAGCGATGGGGTTTCACCATGTTGGCCAGGCTGGTCAAGACAGAGCTGTTAACGGTTGCGTAATGCTGTTTCTTTTACAGCTACTCAATCCTGCTTTTGTAATGTGAAATTAGCTGTAGAGAATACATGAACAAATGAGCATGGCTCCATTCCAGTAAAATGTTATTGTATTTACAGAAACAGACCCTGGGCCAGATTTTA... | GATGTGGGCTCACCGCAACCTCCACCACCCAGGTTCGGGTGATTCTCCTGCCTCAGCCTCCAGAGCAGCTGGGATTACAGGCAATTGCCACCAGGCCTGGCTAATTTTTGTATTTTTAGTAGCGATGGGGTTTCACCATGTTGGCCAGGCTGGTCAAGACAGAGCTGTTAACGGTTGCGTAATGCTGTTTCTTTTACAGCTACTCAATCCTGCTTTTGTAATGTGAAATTAGCTGTAGAGAATACATGAACAAATGAGCATGGCTCCATTCCAGTAAAATGTTATTGTATTTACAGAAACAGACCCTGGGCCAGATTTTA... |
Task1_train_10848 | A mutation found in PNLDC1 (PARN like ribonuclease domain containing exonuclease 1) on Chromosome 6 may be clinically relevant. Is it pathogenic or benign, and if the former, which disease is implicated? | Pathogenic; Spermatogenic failure 57 | TCCCGGGTTCAAGGGATTCTCCTGCCTCAGCCTCCTGAGTAGCTGGGATTACAGGCATCTGCCACCATGCCTGGCTAATTTCTGTATTTTTAGTAGAGTCAGGGTTTCACCGTGTTGGCCAGGTTGGTCTCGAACTCCTGACCTCAGGTGATCCGCCCTCCTCAGCCTCCAAAAGTGCTGGGATTACAGGCATGAGCCACTGCGCCCAGCCGTGAGGCTGGATTTTCTTATGTTTCAATGATCACAACATATCAACAGATTGGATGCAAATGCCGATACAACATTCCAGCCAAATATTAGAGATTTGCAAAAATGTAGAA... | TCCCGGGTTCAAGGGATTCTCCTGCCTCAGCCTCCTGAGTAGCTGGGATTACAGGCATCTGCCACCATGCCTGGCTAATTTCTGTATTTTTAGTAGAGTCAGGGTTTCACCGTGTTGGCCAGGTTGGTCTCGAACTCCTGACCTCAGGTGATCCGCCCTCCTCAGCCTCCAAAAGTGCTGGGATTACAGGCATGAGCCACTGCGCCCAGCCGTGAGGCTGGATTTTCTTATGTTTCAATGATCACAACATATCAACAGATTGGATGCAAATGCCGATACAACATTCCAGCCAAATATTAGAGATTTGCAAAAATGTAGAA... |
Task1_train_10849 | Given this variant in gene IGF2R (insulin like growth factor 2 receptor) on Chromosome 6, classify it as benign or pathogenic. Include the disorder it may cause if applicable. | Pathogenic; Hepatocellular carcinoma | AAGTTCCACTTCTCAGTGGCCTGAGCACAGACGGCACGCACTTTGCAGACTTGAGTTTTTCTGTTAAAATTTAAATTTTTTTTTAAGTGAGCCTAATAGTTTCCTGAACTATTATGTTCAGGGAAGTTATGTTGTTGCTGATTCTGATGGGGGGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGACAGAGACAGAGAGAAGTCGAGTCTAAAGTTCTGTCAGGCTTAGACTATGCCTGAATACTTGAACGTTTCTAGACAGAGTGCCCAATGTTTAAAGAGAATACGACCAAGCCTAACTAACTGCGG... | AAGTTCCACTTCTCAGTGGCCTGAGCACAGACGGCACGCACTTTGCAGACTTGAGTTTTTCTGTTAAAATTTAAATTTTTTTTTAAGTGAGCCTAATAGTTTCCTGAACTATTATGTTCAGGGAAGTTATGTTGTTGCTGATTCTGATGGGGGGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGACAGAGACAGAGAGAAGTCGAGTCTAAAGTTCTGTCAGGCTTAGACTATGCCTGAATACTTGAACGTTTCTAGACAGAGTGCCCAATGTTTAAAGAGAATACGACCAAGCCTAACTAACTGCGG... |
Task1_train_10850 | This mutation is located in gene IGF2R (insulin like growth factor 2 receptor) on Chromosome 6. Is it associated with a disease or is it a benign polymorphism? | Pathogenic; Hepatocellular carcinoma | CAGACTTGAGTTTTTCTGTTAAAATTTAAATTTTTTTTTAAGTGAGCCTAATAGTTTCCTGAACTATTATGTTCAGGGAAGTTATGTTGTTGCTGATTCTGATGGGGGGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGACAGAGACAGAGAGAAGTCGAGTCTAAAGTTCTGTCAGGCTTAGACTATGCCTGAATACTTGAACGTTTCTAGACAGAGTGCCCAATGTTTAAAGAGAATACGACCAAGCCTAACTAACTGCGGGTTTTCTTCTTTTCAGAGATGGGGCTGGCAACTCCTTCGACCTCT... | CAGACTTGAGTTTTTCTGTTAAAATTTAAATTTTTTTTTAAGTGAGCCTAATAGTTTCCTGAACTATTATGTTCAGGGAAGTTATGTTGTTGCTGATTCTGATGGGGGGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGACAGAGACAGAGAGAAGTCGAGTCTAAAGTTCTGTCAGGCTTAGACTATGCCTGAATACTTGAACGTTTCTAGACAGAGTGCCCAATGTTTAAAGAGAATACGACCAAGCCTAACTAACTGCGGGTTTTCTTCTTTTCAGAGATGGGGCTGGCAACTCCTTCGACCTCT... |
Task1_train_10851 | The gene PLG (plasminogen) is located on Chromosome 6, where a mutation has occurred. What is the medical relevance of this mutation? | Pathogenic; Plasminogen deficiency, type I | GTCCTTATTGCCAATTTTATTGCCAAGTGCCTGTTGTGAATTACATCGGAATGAGAGGCAAGTCGCACTTAAGTGAGTAGGATTCTGGTTTTTACTCTCTATTTTGCTTCATCCATTTCAGTTTTCTTCTTCCTCTCTGTCCTTCCTTCCCACTCTGTCCAGAGGAATGTATGCATTGCAGTGGAGAAAACTATGACGGCAAAATTTCCAAGACCATGTCTGGACTGGAATGCCAGGCCTGGGACTCTCAGAGCCCACACGCTCATGGATACATTCCTTCCAAGTAAGTCTCACTGGGAAAAACATTCCATGTTTAATTA... | GTCCTTATTGCCAATTTTATTGCCAAGTGCCTGTTGTGAATTACATCGGAATGAGAGGCAAGTCGCACTTAAGTGAGTAGGATTCTGGTTTTTACTCTCTATTTTGCTTCATCCATTTCAGTTTTCTTCTTCCTCTCTGTCCTTCCTTCCCACTCTGTCCAGAGGAATGTATGCATTGCAGTGGAGAAAACTATGACGGCAAAATTTCCAAGACCATGTCTGGACTGGAATGCCAGGCCTGGGACTCTCAGAGCCCACACGCTCATGGATACATTCCTTCCAAGTAAGTCTCACTGGGAAAAACATTCCATGTTTAATTA... |
Task1_train_10852 | A genomic change on Chromosome 6 affects PLG (plasminogen). Classify this variant as benign or pathogenic, and name the disease if relevant. | Pathogenic; Plasminogen deficiency, type I | TCCTAGTTACCTAAAGGGCTGAAGCGGGAGGATTGCTTGAGTGAGTTCAAGGAGTTCAAGGCAAGCCTGGGCAATAAGTGGGACCCTGTCTCTAAAAACAAACAAAAAAAAGAAAGTCCTTGGAATACAGGGCCAACCTTGTTTCCTTGTTGCCATCTCTGAACACAGCCTTCATCTGATTACCTCCTCCATGCCCGACTGTGCCTAGCACACAGCAGGTGCTCAATGTTTGCTCTTGAAAAAGAGTCTTATCCATGAATGTAAATGTTCAGTGCTACTAAAATCTTTCTTGTCCATTCAGATTTCCAAACAAGAACCTG... | TCCTAGTTACCTAAAGGGCTGAAGCGGGAGGATTGCTTGAGTGAGTTCAAGGAGTTCAAGGCAAGCCTGGGCAATAAGTGGGACCCTGTCTCTAAAAACAAACAAAAAAAAGAAAGTCCTTGGAATACAGGGCCAACCTTGTTTCCTTGTTGCCATCTCTGAACACAGCCTTCATCTGATTACCTCCTCCATGCCCGACTGTGCCTAGCACACAGCAGGTGCTCAATGTTTGCTCTTGAAAAAGAGTCTTATCCATGAATGTAAATGTTCAGTGCTACTAAAATCTTTCTTGTCCATTCAGATTTCCAAACAAGAACCTG... |
Task1_train_10853 | A variant found in Chromosome 6 affects PLG (plasminogen). Please analyze its biological impact: is it benign or pathogenic, and what condition might it cause? | Pathogenic; Angioedema, hereditary, 4 | AACCCCGATAGGGAGCTGCGGCCTTGGTGTTTCACCACCGACCCCAACAAGCGCTGGGAACTTTGTGACATCCCCCGCTGCAGTGAGTATGATGCACACCCAGATTCCAGGATTTGGACCTGCCCTGTTCTTGAAATCAAAAGAAAACATGTGTCAGTGCCTGAGTGCAGCCTCTGAAAAGTGACCTACAAGTCCTATGGGATGTTATTGGTCTTTATTTTATTGCTGGTTTAAAACAGTTATGGTTATTGGTTACTGTGGGTGATTGATCAGAGCGTCCATTTATCATGTTTTTCTTTCTTTGCAACTGAAACTTCTGC... | AACCCCGATAGGGAGCTGCGGCCTTGGTGTTTCACCACCGACCCCAACAAGCGCTGGGAACTTTGTGACATCCCCCGCTGCAGTGAGTATGATGCACACCCAGATTCCAGGATTTGGACCTGCCCTGTTCTTGAAATCAAAAGAAAACATGTGTCAGTGCCTGAGTGCAGCCTCTGAAAAGTGACCTACAAGTCCTATGGGATGTTATTGGTCTTTATTTTATTGCTGGTTTAAAACAGTTATGGTTATTGGTTACTGTGGGTGATTGATCAGAGCGTCCATTTATCATGTTTTTCTTTCTTTGCAACTGAAACTTCTGC... |
Task1_train_10854 | Given this context: Chromosome 6, gene PLG (plasminogen) — does this variant present pathogenic behavior, and if so, what disease does it relate to? | Pathogenic; Plasminogen deficiency, type I | AACCCCGATAGGGAGCTGCGGCCTTGGTGTTTCACCACCGACCCCAACAAGCGCTGGGAACTTTGTGACATCCCCCGCTGCAGTGAGTATGATGCACACCCAGATTCCAGGATTTGGACCTGCCCTGTTCTTGAAATCAAAAGAAAACATGTGTCAGTGCCTGAGTGCAGCCTCTGAAAAGTGACCTACAAGTCCTATGGGATGTTATTGGTCTTTATTTTATTGCTGGTTTAAAACAGTTATGGTTATTGGTTACTGTGGGTGATTGATCAGAGCGTCCATTTATCATGTTTTTCTTTCTTTGCAACTGAAACTTCTGC... | AACCCCGATAGGGAGCTGCGGCCTTGGTGTTTCACCACCGACCCCAACAAGCGCTGGGAACTTTGTGACATCCCCCGCTGCAGTGAGTATGATGCACACCCAGATTCCAGGATTTGGACCTGCCCTGTTCTTGAAATCAAAAGAAAACATGTGTCAGTGCCTGAGTGCAGCCTCTGAAAAGTGACCTACAAGTCCTATGGGATGTTATTGGTCTTTATTTTATTGCTGGTTTAAAACAGTTATGGTTATTGGTTACTGTGGGTGATTGATCAGAGCGTCCATTTATCATGTTTTTCTTTCTTTGCAACTGAAACTTCTGC... |
Task1_train_10855 | This alteration occurs within gene PLG (plasminogen) located on Chromosome 6. Is it associated with a disease or is it a benign variant? | Pathogenic; Angioedema, hereditary, 4 | AACCCCGATAGGGAGCTGCGGCCTTGGTGTTTCACCACCGACCCCAACAAGCGCTGGGAACTTTGTGACATCCCCCGCTGCAGTGAGTATGATGCACACCCAGATTCCAGGATTTGGACCTGCCCTGTTCTTGAAATCAAAAGAAAACATGTGTCAGTGCCTGAGTGCAGCCTCTGAAAAGTGACCTACAAGTCCTATGGGATGTTATTGGTCTTTATTTTATTGCTGGTTTAAAACAGTTATGGTTATTGGTTACTGTGGGTGATTGATCAGAGCGTCCATTTATCATGTTTTTCTTTCTTTGCAACTGAAACTTCTGC... | AACCCCGATAGGGAGCTGCGGCCTTGGTGTTTCACCACCGACCCCAACAAGCGCTGGGAACTTTGTGACATCCCCCGCTGCAGTGAGTATGATGCACACCCAGATTCCAGGATTTGGACCTGCCCTGTTCTTGAAATCAAAAGAAAACATGTGTCAGTGCCTGAGTGCAGCCTCTGAAAAGTGACCTACAAGTCCTATGGGATGTTATTGGTCTTTATTTTATTGCTGGTTTAAAACAGTTATGGTTATTGGTTACTGTGGGTGATTGATCAGAGCGTCCATTTATCATGTTTTTCTTTCTTTGCAACTGAAACTTCTGC... |
Task1_train_10856 | This is a variant in PLG (plasminogen), located on Chromosome 6. Is this mutation a likely cause of disease or not? | Pathogenic; PLG-related disorder | AACCCCGATAGGGAGCTGCGGCCTTGGTGTTTCACCACCGACCCCAACAAGCGCTGGGAACTTTGTGACATCCCCCGCTGCAGTGAGTATGATGCACACCCAGATTCCAGGATTTGGACCTGCCCTGTTCTTGAAATCAAAAGAAAACATGTGTCAGTGCCTGAGTGCAGCCTCTGAAAAGTGACCTACAAGTCCTATGGGATGTTATTGGTCTTTATTTTATTGCTGGTTTAAAACAGTTATGGTTATTGGTTACTGTGGGTGATTGATCAGAGCGTCCATTTATCATGTTTTTCTTTCTTTGCAACTGAAACTTCTGC... | AACCCCGATAGGGAGCTGCGGCCTTGGTGTTTCACCACCGACCCCAACAAGCGCTGGGAACTTTGTGACATCCCCCGCTGCAGTGAGTATGATGCACACCCAGATTCCAGGATTTGGACCTGCCCTGTTCTTGAAATCAAAAGAAAACATGTGTCAGTGCCTGAGTGCAGCCTCTGAAAAGTGACCTACAAGTCCTATGGGATGTTATTGGTCTTTATTTTATTGCTGGTTTAAAACAGTTATGGTTATTGGTTACTGTGGGTGATTGATCAGAGCGTCCATTTATCATGTTTTTCTTTCTTTGCAACTGAAACTTCTGC... |
Task1_train_10857 | The gene PLG (plasminogen) is located on Chromosome 6, where a mutation has occurred. What is the medical relevance of this mutation? | Pathogenic; Dysplasminogenemia | TTTCTTTTCTCTTTTTTCTTTTCTTTTCTTTTTTTTTTTTTTTTTTTTTTTTTTTGAGATGGAGCCTCACTCTGTCACCCAGGCTGGAGTGCAGTGGCGCAATCTCGGCTCACTGCAAACTCCACCTCCCAGGTTCAAGTGATTCTCCTGCTTCAGCCTCCTGAGGAGCTGGGACTACAAGCATGTGCCACCAGGCCCAGCTAATTTTTGTATTTTTGGTAGAGACAGAGTTTCGCCATGTTGGCCAGACTGGTCTCAAACTTCTGACCTCAGACGGTCCATCACCTTGGCCTTCCAAAGTGCTGACAGTACAGGTGTGA... | TTTCTTTTCTCTTTTTTCTTTTCTTTTCTTTTTTTTTTTTTTTTTTTTTTTTTTTGAGATGGAGCCTCACTCTGTCACCCAGGCTGGAGTGCAGTGGCGCAATCTCGGCTCACTGCAAACTCCACCTCCCAGGTTCAAGTGATTCTCCTGCTTCAGCCTCCTGAGGAGCTGGGACTACAAGCATGTGCCACCAGGCCCAGCTAATTTTTGTATTTTTGGTAGAGACAGAGTTTCGCCATGTTGGCCAGACTGGTCTCAAACTTCTGACCTCAGACGGTCCATCACCTTGGCCTTCCAAAGTGCTGACAGTACAGGTGTGA... |
Task1_train_10858 | The gene PLG (plasminogen) on Chromosome 6 contains a mutation. Based on this information, is the variant pathogenic or benign? Provide the disease if relevant. | Pathogenic; Dysplasminogenemia | TCCAAGTCCACTGAAGACCAGCATCCTGAGATTGCCTGGGAAGGTGGTACAGGGCAGTGATGAAGATCATGGGAGCCACACTGCCCAGCTTCGCATTTGGGCTTCTCCTAGGGACACCAAGAGGGAGGAAGGAGGGGTTAGGATGGTATGAAAGATTCTACTTGGCCAATATTATTGTAATGCGGCATTGTGATCTCTGGATTTAGCATGAGTTGATAGCTGACTTTTTCTGCAGAAGCATCTTGGTGGCACCTCTAACTCAAAGTCCCTCGATGGAGTCAGTTCCAGTTCTCCACTTCTGGCCCCATCTGGTACACACC... | TCCAAGTCCACTGAAGACCAGCATCCTGAGATTGCCTGGGAAGGTGGTACAGGGCAGTGATGAAGATCATGGGAGCCACACTGCCCAGCTTCGCATTTGGGCTTCTCCTAGGGACACCAAGAGGGAGGAAGGAGGGGTTAGGATGGTATGAAAGATTCTACTTGGCCAATATTATTGTAATGCGGCATTGTGATCTCTGGATTTAGCATGAGTTGATAGCTGACTTTTTCTGCAGAAGCATCTTGGTGGCACCTCTAACTCAAAGTCCCTCGATGGAGTCAGTTCCAGTTCTCCACTTCTGGCCCCATCTGGTACACACC... |
Task1_train_10859 | A variant was discovered in gene PLG (plasminogen), Chromosome 6. Please indicate if this mutation results in a known disease or if it's non-harmful. | Pathogenic; Angioedema, hereditary, 4 | TTCTCCTGCTCTTCCCTTCATGTTTCCAGATGTTCCCTGACTTGGATATTCCAAACGCAGAGTTTGGAGGTGTTGAGGCCAAGGGGTTTTTCCAGGTCAGCCATCATCTGCAATCACTGAGCTGATCCTGCTGCTGGACTTTCCCTGTTGCCCTCTCCCCAACGCCCCATCGGGGAGGGCTTCAATCCTCAGGTCACCTGTGGCCTTTCTGCCCTCAGAGGTGCCATCTCTACATCTACCACTGGAAGGCAGCACCTACTCACAGATTGCATCAATTTCCCAGCAACTCATGGTGGGTTTTCCCCCTTATCAGCGTGTTT... | TTCTCCTGCTCTTCCCTTCATGTTTCCAGATGTTCCCTGACTTGGATATTCCAAACGCAGAGTTTGGAGGTGTTGAGGCCAAGGGGTTTTTCCAGGTCAGCCATCATCTGCAATCACTGAGCTGATCCTGCTGCTGGACTTTCCCTGTTGCCCTCTCCCCAACGCCCCATCGGGGAGGGCTTCAATCCTCAGGTCACCTGTGGCCTTTCTGCCCTCAGAGGTGCCATCTCTACATCTACCACTGGAAGGCAGCACCTACTCACAGATTGCATCAATTTCCCAGCAACTCATGGTGGGTTTTCCCCCTTATCAGCGTGTTT... |
Task1_train_10860 | Consider this mutation in PRKN (parkin RBR E3 ubiquitin protein ligase) on Chromosome 6. Is this a benign change or a disease-causing variant? | Pathogenic; Autosomal recessive juvenile Parkinson disease 2 | CTCCACGTGACAGAAGGGAGCCACCTGATTTGTCGCATCGGGCCAGTGTAAGGAAGTGTAATTTAGTGGGACTGCCAGTGACACTAAGTCAGGCCTTGATCAGGGTCTGGACTCAGTATGGACACGAGCCACTGGGTGCAGGGGGCTCATGCCTGCCACCTCTCTTTTTTTCCCTTACTATAGAGACTTTGATCTGTCCACCATTTCTATGTGAGCTTTGGGCTTCCTGTCACAGGTCTGTTGTCACCGTGGGGCCATGTTGGAGTCGGTAGATTTTCAGACAGTGAAGCCACATGAAGCTGTGAATGCTGATGTGGCTG... | CTCCACGTGACAGAAGGGAGCCACCTGATTTGTCGCATCGGGCCAGTGTAAGGAAGTGTAATTTAGTGGGACTGCCAGTGACACTAAGTCAGGCCTTGATCAGGGTCTGGACTCAGTATGGACACGAGCCACTGGGTGCAGGGGGCTCATGCCTGCCACCTCTCTTTTTTTCCCTTACTATAGAGACTTTGATCTGTCCACCATTTCTATGTGAGCTTTGGGCTTCCTGTCACAGGTCTGTTGTCACCGTGGGGCCATGTTGGAGTCGGTAGATTTTCAGACAGTGAAGCCACATGAAGCTGTGAATGCTGATGTGGCTG... |
Task1_train_10861 | This mutation is located in gene PRKN (parkin RBR E3 ubiquitin protein ligase) on Chromosome 6. Is it associated with a disease or is it a benign polymorphism? | Pathogenic; not provided | CTTCACTAGATTTTGGATGCTTTTGTTAAAAAGAAAGGCACAATAACTTTCAACAAGTTTTCCTTAACAATATGTTAACATATATTATGTGAATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAA... | CTTCACTAGATTTTGGATGCTTTTGTTAAAAAGAAAGGCACAATAACTTTCAACAAGTTTTCCTTAACAATATGTTAACATATATTATGTGAATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAA... |
Task1_train_10862 | This alteration in PRKN (parkin RBR E3 ubiquitin protein ligase) on Chromosome 6 may affect gene function. Does it lead to a disease or is it benign? | Pathogenic; See cases | AAAAAGAAAGGCACAATAACTTTCAACAAGTTTTCCTTAACAATATGTTAACATATATTATGTGAATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGC... | AAAAAGAAAGGCACAATAACTTTCAACAAGTTTTCCTTAACAATATGTTAACATATATTATGTGAATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGC... |
Task1_train_10863 | A sequence alteration has been identified in PRKN (parkin RBR E3 ubiquitin protein ligase) on Chromosome 6. Is it disease-inducing or harmless? | Pathogenic; Lung carcinoma | AAAAAGAAAGGCACAATAACTTTCAACAAGTTTTCCTTAACAATATGTTAACATATATTATGTGAATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGC... | AAAAAGAAAGGCACAATAACTTTCAACAAGTTTTCCTTAACAATATGTTAACATATATTATGTGAATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGC... |
Task1_train_10864 | Mutation context: Chromosome 6, Gene PRKN (parkin RBR E3 ubiquitin protein ligase). Determine if this variant is likely to be benign or pathogenic. Mention the disease if applicable. | Pathogenic; Autosomal recessive juvenile Parkinson disease 2 | AAAAAGAAAGGCACAATAACTTTCAACAAGTTTTCCTTAACAATATGTTAACATATATTATGTGAATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGC... | AAAAAGAAAGGCACAATAACTTTCAACAAGTTTTCCTTAACAATATGTTAACATATATTATGTGAATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGC... |
Task1_train_10865 | The variant affects gene PRKN (parkin RBR E3 ubiquitin protein ligase), which is on Chromosome 6. Please evaluate whether this mutation is benign or pathogenic and specify the disease if necessary. | Pathogenic; Leprosy, susceptibility to, 2 | AAAAAGAAAGGCACAATAACTTTCAACAAGTTTTCCTTAACAATATGTTAACATATATTATGTGAATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGC... | AAAAAGAAAGGCACAATAACTTTCAACAAGTTTTCCTTAACAATATGTTAACATATATTATGTGAATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGC... |
Task1_train_10866 | A mutation found in PRKN (parkin RBR E3 ubiquitin protein ligase) on Chromosome 6 may be clinically relevant. Is it pathogenic or benign, and if the former, which disease is implicated? | Pathogenic; Ovarian neoplasm | AAAAAGAAAGGCACAATAACTTTCAACAAGTTTTCCTTAACAATATGTTAACATATATTATGTGAATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGC... | AAAAAGAAAGGCACAATAACTTTCAACAAGTTTTCCTTAACAATATGTTAACATATATTATGTGAATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGC... |
Task1_train_10867 | Consider a variant on Chromosome 6 in gene PRKN (parkin RBR E3 ubiquitin protein ligase). Determine its clinical classification and disease relevance. | Pathogenic; Young-onset Parkinson disease | AAAAAGAAAGGCACAATAACTTTCAACAAGTTTTCCTTAACAATATGTTAACATATATTATGTGAATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGC... | AAAAAGAAAGGCACAATAACTTTCAACAAGTTTTCCTTAACAATATGTTAACATATATTATGTGAATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGC... |
Task1_train_10868 | Given this context: Chromosome 6, gene PRKN (parkin RBR E3 ubiquitin protein ligase) — does this variant present pathogenic behavior, and if so, what disease does it relate to? | Pathogenic; Autosomal recessive juvenile Parkinson disease 2 | AAAAAGAAAGGCACAATAACTTTCAACAAGTTTTCCTTAACAATATGTTAACATATATTATGTGAATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGC... | AAAAAGAAAGGCACAATAACTTTCAACAAGTTTTCCTTAACAATATGTTAACATATATTATGTGAATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGC... |
Task1_train_10869 | A mutation on Chromosome 6 affecting PRKN (parkin RBR E3 ubiquitin protein ligase) has been found. Is it harmful or harmless? What disease, if any, does it cause? | Pathogenic; Parkinson disease 12 | AAAAAGAAAGGCACAATAACTTTCAACAAGTTTTCCTTAACAATATGTTAACATATATTATGTGAATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGC... | AAAAAGAAAGGCACAATAACTTTCAACAAGTTTTCCTTAACAATATGTTAACATATATTATGTGAATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGC... |
Task1_train_10870 | Here is a variant affecting PRKN (parkin RBR E3 ubiquitin protein ligase) on Chromosome 6. Please identify whether it is a benign mutation or associated with a disorder. | Pathogenic; Lung cancer | AAAAAGAAAGGCACAATAACTTTCAACAAGTTTTCCTTAACAATATGTTAACATATATTATGTGAATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGC... | AAAAAGAAAGGCACAATAACTTTCAACAAGTTTTCCTTAACAATATGTTAACATATATTATGTGAATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGC... |
Task1_train_10871 | This alteration occurs within gene PRKN (parkin RBR E3 ubiquitin protein ligase) located on Chromosome 6. Is it associated with a disease or is it a benign variant? | Pathogenic; Ovarian cancer | AAAAAGAAAGGCACAATAACTTTCAACAAGTTTTCCTTAACAATATGTTAACATATATTATGTGAATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGC... | AAAAAGAAAGGCACAATAACTTTCAACAAGTTTTCCTTAACAATATGTTAACATATATTATGTGAATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGC... |
Task1_train_10872 | A mutation on Chromosome 6 affecting PRKN (parkin RBR E3 ubiquitin protein ligase) has been found. Is it harmful or harmless? What disease, if any, does it cause? | Pathogenic; Autosomal recessive juvenile Parkinson disease 2 | AAAAAGAAAGGCACAATAACTTTCAACAAGTTTTCCTTAACAATATGTTAACATATATTATGTGAATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGC... | AAAAAGAAAGGCACAATAACTTTCAACAAGTTTTCCTTAACAATATGTTAACATATATTATGTGAATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGC... |
Task1_train_10873 | The variant affects gene PRKN (parkin RBR E3 ubiquitin protein ligase), which is on Chromosome 6. Please evaluate whether this mutation is benign or pathogenic and specify the disease if necessary. | Pathogenic; Autosomal recessive juvenile Parkinson disease 2 | ATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGCAGTCATTTATACATAGAGAGAGATAGGAACTTTTACTTCACTCCAGGTACATAAATTACCTCAAA... | ATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGCAGTCATTTATACATAGAGAGAGATAGGAACTTTTACTTCACTCCAGGTACATAAATTACCTCAAA... |
Task1_train_10874 | This sequence change occurs on Chromosome 6, altering PRKN (parkin RBR E3 ubiquitin protein ligase). What is the medical significance of this variant — is it benign or linked to a disease? | Pathogenic; Ovarian cancer | ATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGCAGTCATTTATACATAGAGAGAGATAGGAACTTTTACTTCACTCCAGGTACATAAATTACCTCAAA... | ATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGCAGTCATTTATACATAGAGAGAGATAGGAACTTTTACTTCACTCCAGGTACATAAATTACCTCAAA... |
Task1_train_10875 | A genetic alteration is present in PRKN (parkin RBR E3 ubiquitin protein ligase) on Chromosome 6. Is this variant benign or disease-causing, and if the latter, which condition is involved? | Pathogenic; Autosomal recessive juvenile Parkinson disease 2 | ATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGCAGTCATTTATACATAGAGAGAGATAGGAACTTTTACTTCACTCCAGGTACATAAATTACCTCAAA... | ATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGCAGTCATTTATACATAGAGAGAGATAGGAACTTTTACTTCACTCCAGGTACATAAATTACCTCAAA... |
Task1_train_10876 | This sequence change occurs on Chromosome 6, altering PRKN (parkin RBR E3 ubiquitin protein ligase). What is the medical significance of this variant — is it benign or linked to a disease? | Pathogenic; Lung cancer | ATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGCAGTCATTTATACATAGAGAGAGATAGGAACTTTTACTTCACTCCAGGTACATAAATTACCTCAAA... | ATCTTAGTTTTAAAAATCATTGCATTATTGGTAGATATGCTTAAAAGTGAGTATCATAATTTACAAAGTCAACAAAGAAATTAATTTATTCCATTTGGATCTTTTTATCATTTGGAGGTATATTTTTCAGCTATAATTGACATTAAAACTAAATCTTGAAATAAATTGAACTTAAAACCTCACCATTGAGTCAAGGTATCCCATAGTTTCAAATTAAGTTTTGAAGAATTAATGAAACATATTTAGTCACATTGCAGTCATTTATACATAGAGAGAGATAGGAACTTTTACTTCACTCCAGGTACATAAATTACCTCAAA... |
Task1_train_10877 | Gene PRKN (parkin RBR E3 ubiquitin protein ligase) on Chromosome 6 is impacted by this variant. Evaluate whether it is clinically benign or pathogenic and name the disorder if relevant. | Pathogenic; Autosomal recessive juvenile Parkinson disease 2 | AGCAGGAAACGGGGAGGGCAACGCTCTTAGTAAGATAATACCATCATCACCACATATTTTAATGTCATGTTTACCAACCTTAATGGAAAGTTTAAAATACTGGCTGATGAGCTGTTTTCTGACTTACAGAAGAGTATTTTGAATTTTTCCTTTGAAAAACTGAACAGTGACTTAAATTACCTGCTGCTATCAGCGCAGTCAAGCCCTCGCTTTTAGCACTTTTCAATCCCTTTCCCGAAACACCAGAATCCCCATCTTAGCTGTTCTTCTTGCATGTTGAAAGCGTTAGCCATACACAGTCATTCACCTTGCCAAGAGAG... | AGCAGGAAACGGGGAGGGCAACGCTCTTAGTAAGATAATACCATCATCACCACATATTTTAATGTCATGTTTACCAACCTTAATGGAAAGTTTAAAATACTGGCTGATGAGCTGTTTTCTGACTTACAGAAGAGTATTTTGAATTTTTCCTTTGAAAAACTGAACAGTGACTTAAATTACCTGCTGCTATCAGCGCAGTCAAGCCCTCGCTTTTAGCACTTTTCAATCCCTTTCCCGAAACACCAGAATCCCCATCTTAGCTGTTCTTCTTGCATGTTGAAAGCGTTAGCCATACACAGTCATTCACCTTGCCAAGAGAG... |
Task1_train_10878 | This alteration occurs within gene PRKN (parkin RBR E3 ubiquitin protein ligase) located on Chromosome 6. Is it associated with a disease or is it a benign variant? | Pathogenic; not provided | GGAAAGTTTAAAATACTGGCTGATGAGCTGTTTTCTGACTTACAGAAGAGTATTTTGAATTTTTCCTTTGAAAAACTGAACAGTGACTTAAATTACCTGCTGCTATCAGCGCAGTCAAGCCCTCGCTTTTAGCACTTTTCAATCCCTTTCCCGAAACACCAGAATCCCCATCTTAGCTGTTCTTCTTGCATGTTGAAAGCGTTAGCCATACACAGTCATTCACCTTGCCAAGAGAGGCTGAAGCGCTATATTTTAAAGGCAATGTTGTGGTGCTTCCTGCCACAGCAGTGACTAAACATGCAGCAAAGAGAAAATCACGT... | GGAAAGTTTAAAATACTGGCTGATGAGCTGTTTTCTGACTTACAGAAGAGTATTTTGAATTTTTCCTTTGAAAAACTGAACAGTGACTTAAATTACCTGCTGCTATCAGCGCAGTCAAGCCCTCGCTTTTAGCACTTTTCAATCCCTTTCCCGAAACACCAGAATCCCCATCTTAGCTGTTCTTCTTGCATGTTGAAAGCGTTAGCCATACACAGTCATTCACCTTGCCAAGAGAGGCTGAAGCGCTATATTTTAAAGGCAATGTTGTGGTGCTTCCTGCCACAGCAGTGACTAAACATGCAGCAAAGAGAAAATCACGT... |
Task1_train_10879 | Chromosome 6 houses a mutation in gene PRKN (parkin RBR E3 ubiquitin protein ligase). Classify its clinical impact — is it pathogenic or benign, and what disease does it lead to if any? | Pathogenic; Lung cancer | AAAGTTTAAAATACTGGCTGATGAGCTGTTTTCTGACTTACAGAAGAGTATTTTGAATTTTTCCTTTGAAAAACTGAACAGTGACTTAAATTACCTGCTGCTATCAGCGCAGTCAAGCCCTCGCTTTTAGCACTTTTCAATCCCTTTCCCGAAACACCAGAATCCCCATCTTAGCTGTTCTTCTTGCATGTTGAAAGCGTTAGCCATACACAGTCATTCACCTTGCCAAGAGAGGCTGAAGCGCTATATTTTAAAGGCAATGTTGTGGTGCTTCCTGCCACAGCAGTGACTAAACATGCAGCAAAGAGAAAATCACGTCT... | AAAGTTTAAAATACTGGCTGATGAGCTGTTTTCTGACTTACAGAAGAGTATTTTGAATTTTTCCTTTGAAAAACTGAACAGTGACTTAAATTACCTGCTGCTATCAGCGCAGTCAAGCCCTCGCTTTTAGCACTTTTCAATCCCTTTCCCGAAACACCAGAATCCCCATCTTAGCTGTTCTTCTTGCATGTTGAAAGCGTTAGCCATACACAGTCATTCACCTTGCCAAGAGAGGCTGAAGCGCTATATTTTAAAGGCAATGTTGTGGTGCTTCCTGCCACAGCAGTGACTAAACATGCAGCAAAGAGAAAATCACGTCT... |
Task1_train_10880 | Here is a genetic alteration in PRKN (parkin RBR E3 ubiquitin protein ligase) on Chromosome 6. Based on the data, is it a benign variant or a cause of disease? | Pathogenic; Autosomal recessive juvenile Parkinson disease 2 | AAAGTTTAAAATACTGGCTGATGAGCTGTTTTCTGACTTACAGAAGAGTATTTTGAATTTTTCCTTTGAAAAACTGAACAGTGACTTAAATTACCTGCTGCTATCAGCGCAGTCAAGCCCTCGCTTTTAGCACTTTTCAATCCCTTTCCCGAAACACCAGAATCCCCATCTTAGCTGTTCTTCTTGCATGTTGAAAGCGTTAGCCATACACAGTCATTCACCTTGCCAAGAGAGGCTGAAGCGCTATATTTTAAAGGCAATGTTGTGGTGCTTCCTGCCACAGCAGTGACTAAACATGCAGCAAAGAGAAAATCACGTCT... | AAAGTTTAAAATACTGGCTGATGAGCTGTTTTCTGACTTACAGAAGAGTATTTTGAATTTTTCCTTTGAAAAACTGAACAGTGACTTAAATTACCTGCTGCTATCAGCGCAGTCAAGCCCTCGCTTTTAGCACTTTTCAATCCCTTTCCCGAAACACCAGAATCCCCATCTTAGCTGTTCTTCTTGCATGTTGAAAGCGTTAGCCATACACAGTCATTCACCTTGCCAAGAGAGGCTGAAGCGCTATATTTTAAAGGCAATGTTGTGGTGCTTCCTGCCACAGCAGTGACTAAACATGCAGCAAAGAGAAAATCACGTCT... |
Task1_train_10881 | This mutation occurs in PRKN (parkin RBR E3 ubiquitin protein ligase) on Chromosome 6. Does this change lead to a known medical condition, or is it benign? | Pathogenic; Ovarian cancer | AAAGTTTAAAATACTGGCTGATGAGCTGTTTTCTGACTTACAGAAGAGTATTTTGAATTTTTCCTTTGAAAAACTGAACAGTGACTTAAATTACCTGCTGCTATCAGCGCAGTCAAGCCCTCGCTTTTAGCACTTTTCAATCCCTTTCCCGAAACACCAGAATCCCCATCTTAGCTGTTCTTCTTGCATGTTGAAAGCGTTAGCCATACACAGTCATTCACCTTGCCAAGAGAGGCTGAAGCGCTATATTTTAAAGGCAATGTTGTGGTGCTTCCTGCCACAGCAGTGACTAAACATGCAGCAAAGAGAAAATCACGTCT... | AAAGTTTAAAATACTGGCTGATGAGCTGTTTTCTGACTTACAGAAGAGTATTTTGAATTTTTCCTTTGAAAAACTGAACAGTGACTTAAATTACCTGCTGCTATCAGCGCAGTCAAGCCCTCGCTTTTAGCACTTTTCAATCCCTTTCCCGAAACACCAGAATCCCCATCTTAGCTGTTCTTCTTGCATGTTGAAAGCGTTAGCCATACACAGTCATTCACCTTGCCAAGAGAGGCTGAAGCGCTATATTTTAAAGGCAATGTTGTGGTGCTTCCTGCCACAGCAGTGACTAAACATGCAGCAAAGAGAAAATCACGTCT... |
Task1_train_10882 | Given a variant located on Chromosome 6 and affecting PRKN (parkin RBR E3 ubiquitin protein ligase), assess whether it is benign or pathogenic. Indicate the associated disease if pathogenic. | Pathogenic; Autosomal recessive juvenile Parkinson disease 2 | AAAGTTTAAAATACTGGCTGATGAGCTGTTTTCTGACTTACAGAAGAGTATTTTGAATTTTTCCTTTGAAAAACTGAACAGTGACTTAAATTACCTGCTGCTATCAGCGCAGTCAAGCCCTCGCTTTTAGCACTTTTCAATCCCTTTCCCGAAACACCAGAATCCCCATCTTAGCTGTTCTTCTTGCATGTTGAAAGCGTTAGCCATACACAGTCATTCACCTTGCCAAGAGAGGCTGAAGCGCTATATTTTAAAGGCAATGTTGTGGTGCTTCCTGCCACAGCAGTGACTAAACATGCAGCAAAGAGAAAATCACGTCT... | AAAGTTTAAAATACTGGCTGATGAGCTGTTTTCTGACTTACAGAAGAGTATTTTGAATTTTTCCTTTGAAAAACTGAACAGTGACTTAAATTACCTGCTGCTATCAGCGCAGTCAAGCCCTCGCTTTTAGCACTTTTCAATCCCTTTCCCGAAACACCAGAATCCCCATCTTAGCTGTTCTTCTTGCATGTTGAAAGCGTTAGCCATACACAGTCATTCACCTTGCCAAGAGAGGCTGAAGCGCTATATTTTAAAGGCAATGTTGTGGTGCTTCCTGCCACAGCAGTGACTAAACATGCAGCAAAGAGAAAATCACGTCT... |
Task1_train_10883 | This variant affects gene LOC126859871, PRKN (MED14-independent group 3 enhancer GRCh37_chr6:162621359-162622558| parkin RBR E3 ubiquitin protein ligase) located on Chromosome 6. Evaluate its biological effect and specify any disease association. | Pathogenic; Autosomal recessive juvenile Parkinson disease 2 | CATCTAACCTAACTTCTCATCACCTGAGTGATCACTGTGGACATATGAGTATGTGACATCTATCGTAATTATATCTGTGTGTTAAAAAAAAAAAAAGCTGAAAAGCTAAAGGAGTTAAATGTTTAGATTAGACAGTCCAGGTTCAACCTCCAAGTCCACACTCATAAGTTCCTCTTTTCTTGGGCAAATGCCTTAATCTCTTTAAGCCTTATTATCCTCACATCTAAAATAGGGTTACTAATAATGCTTAACTGAGAGTGTTCTTATGAAATAATTAAACCAGATAATGCCTGAAAAGAATTTAGCTTGGAATTCAATAT... | CATCTAACCTAACTTCTCATCACCTGAGTGATCACTGTGGACATATGAGTATGTGACATCTATCGTAATTATATCTGTGTGTTAAAAAAAAAAAAAGCTGAAAAGCTAAAGGAGTTAAATGTTTAGATTAGACAGTCCAGGTTCAACCTCCAAGTCCACACTCATAAGTTCCTCTTTTCTTGGGCAAATGCCTTAATCTCTTTAAGCCTTATTATCCTCACATCTAAAATAGGGTTACTAATAATGCTTAACTGAGAGTGTTCTTATGAAATAATTAAACCAGATAATGCCTGAAAAGAATTTAGCTTGGAATTCAATAT... |
Task1_train_10884 | The gene PRKN (parkin RBR E3 ubiquitin protein ligase) is located on Chromosome 6, where a mutation has occurred. What is the medical relevance of this mutation? | Pathogenic; Autosomal recessive juvenile Parkinson disease 2 | CTTCAATGCCAAGTTAGTCAAGGTTATGTGAAATATAGCCCATATTTTATTTTTTGTCCAATCTTCAACATCTCTCTTCAGGTTCTAGAAGAACAAGAACCCATCCTTTTTGGCAAGCATTCTCTATGCTCATTCCCCTATTCCTCCATCTACAGAATCCTACCTCAACTCAATTCATCCAAGAAGTTCTTCCTGGTGACTTCCAACCAGATGTGTTTTCTCCACCTTTAAAACTTCATAATATTTTCAGGTGCGATACGGCAGTTATGTTTCATATTCTTATATTATAGCTATTAGGTTGAACAACATGAAATTGTTGA... | CTTCAATGCCAAGTTAGTCAAGGTTATGTGAAATATAGCCCATATTTTATTTTTTGTCCAATCTTCAACATCTCTCTTCAGGTTCTAGAAGAACAAGAACCCATCCTTTTTGGCAAGCATTCTCTATGCTCATTCCCCTATTCCTCCATCTACAGAATCCTACCTCAACTCAATTCATCCAAGAAGTTCTTCCTGGTGACTTCCAACCAGATGTGTTTTCTCCACCTTTAAAACTTCATAATATTTTCAGGTGCGATACGGCAGTTATGTTTCATATTCTTATATTATAGCTATTAGGTTGAACAACATGAAATTGTTGA... |
Task1_train_10885 | This genomic variant is located on Chromosome 6, within the PRKN (parkin RBR E3 ubiquitin protein ligase) gene. Can you determine its pathogenicity and name any linked disease? | Pathogenic; not provided | TATTTTATTTTTTGTCCAATCTTCAACATCTCTCTTCAGGTTCTAGAAGAACAAGAACCCATCCTTTTTGGCAAGCATTCTCTATGCTCATTCCCCTATTCCTCCATCTACAGAATCCTACCTCAACTCAATTCATCCAAGAAGTTCTTCCTGGTGACTTCCAACCAGATGTGTTTTCTCCACCTTTAAAACTTCATAATATTTTCAGGTGCGATACGGCAGTTATGTTTCATATTCTTATATTATAGCTATTAGGTTGAACAACATGAAATTGTTGAACCTGTAAAAATGGCAATCCCATATGGTTCAATCTAATATTT... | TATTTTATTTTTTGTCCAATCTTCAACATCTCTCTTCAGGTTCTAGAAGAACAAGAACCCATCCTTTTTGGCAAGCATTCTCTATGCTCATTCCCCTATTCCTCCATCTACAGAATCCTACCTCAACTCAATTCATCCAAGAAGTTCTTCCTGGTGACTTCCAACCAGATGTGTTTTCTCCACCTTTAAAACTTCATAATATTTTCAGGTGCGATACGGCAGTTATGTTTCATATTCTTATATTATAGCTATTAGGTTGAACAACATGAAATTGTTGAACCTGTAAAAATGGCAATCCCATATGGTTCAATCTAATATTT... |
Task1_train_10886 | This variant lies on Chromosome 6 and affects the gene PDE10A (phosphodiesterase 10A). Based on this context, is the mutation pathogenic or benign? If pathogenic, what disease does it cause? | Pathogenic; not provided | GCCATCACCCCACAAGGCTGAGCTGTGGACTTGTGACAAGGACATTAGTGCTTATAAATGCAAATATACTGACCATATGATCCTTAATAGAAAAGGCTTGCTGACTCCTATTGTGAGGACATGTTTTTGGAAAACAGGACTAAGGTGCATAGAAACAGTGACATAGCTAACGGTAGGTAGTTACATGGGAGTCTTCAGAGCCTGGCTTCTCTCATTTAGCATAAAGGTTTTTGAGATTCATCCATGTTGTTGCATGTCTTAGTGGTTAAGTCCTTTTTATTGCTGAGTTATACCTCTATTGAATGGACATATCGTATTTT... | GCCATCACCCCACAAGGCTGAGCTGTGGACTTGTGACAAGGACATTAGTGCTTATAAATGCAAATATACTGACCATATGATCCTTAATAGAAAAGGCTTGCTGACTCCTATTGTGAGGACATGTTTTTGGAAAACAGGACTAAGGTGCATAGAAACAGTGACATAGCTAACGGTAGGTAGTTACATGGGAGTCTTCAGAGCCTGGCTTCTCTCATTTAGCATAAAGGTTTTTGAGATTCATCCATGTTGTTGCATGTCTTAGTGGTTAAGTCCTTTTTATTGCTGAGTTATACCTCTATTGAATGGACATATCGTATTTT... |
Task1_train_10887 | Consider this mutation in PDE10A (phosphodiesterase 10A) on Chromosome 6. Is this a benign change or a disease-causing variant? | Pathogenic; Striatal degeneration, autosomal dominant 2 | TGGCACAAGGAACACTAGAATGCTGGTCTCTACCATCGTGCTTTCTACCACACATATAACCAAACTCACAGGTTACACGTGAGCTTGAGATATTATACAGAACTGAATTTTATGGTGTTTGCAATTCAAGCACTATACAGAAATAACGCAATGTACAACTTCTAGTATTTTTACCTAATTTGTTAAATTTTAAAATAATCAAAATACAAGGATTGTCTGTTTTTTATATCTAATATCAGTATTTTTCCTTTGCAAAAATATTTTCATACTTATATTTTTCTCATTACTATACCATCATCACACAGGCACTCATTTCAAAA... | TGGCACAAGGAACACTAGAATGCTGGTCTCTACCATCGTGCTTTCTACCACACATATAACCAAACTCACAGGTTACACGTGAGCTTGAGATATTATACAGAACTGAATTTTATGGTGTTTGCAATTCAAGCACTATACAGAAATAACGCAATGTACAACTTCTAGTATTTTTACCTAATTTGTTAAATTTTAAAATAATCAAAATACAAGGATTGTCTGTTTTTTATATCTAATATCAGTATTTTTCCTTTGCAAAAATATTTTCATACTTATATTTTTCTCATTACTATACCATCATCACACAGGCACTCATTTCAAAA... |
Task1_train_10888 | The following genetic variant occurs in PDE10A (phosphodiesterase 10A) on Chromosome 6. Classify its clinical effect — pathogenic or benign — and list any associated condition. | Pathogenic; Infantile-onset generalized dyskinesia with orofacial involvement | GAATTTATACATTAAACTTATGAATATTAGCATTATTGGCTCAGATTATGCTAAAATATGTATACTTTTTAATACTGTATCAAAAATCAAATGCCAGTAATTGAACATCTTGAAATACTTTTGAAAGTGCCTTTCTATGTTGCATTTTCCGGCGGGCTGTGCTCCAGGTAAGTTAGACCAGAAACGCAGGATCCGGCCTGGTGGCAGAAGACTGGAACAGCCACAGCTGAGAATCCCCATTCCTTGACTGGCCTGAGCCTACTACAGTAAGGCAGCTTAGGGATCTAGACACAAAGCCCTAGGACTTTTAGAGTCATCTG... | GAATTTATACATTAAACTTATGAATATTAGCATTATTGGCTCAGATTATGCTAAAATATGTATACTTTTTAATACTGTATCAAAAATCAAATGCCAGTAATTGAACATCTTGAAATACTTTTGAAAGTGCCTTTCTATGTTGCATTTTCCGGCGGGCTGTGCTCCAGGTAAGTTAGACCAGAAACGCAGGATCCGGCCTGGTGGCAGAAGACTGGAACAGCCACAGCTGAGAATCCCCATTCCTTGACTGGCCTGAGCCTACTACAGTAAGGCAGCTTAGGGATCTAGACACAAAGCCCTAGGACTTTTAGAGTCATCTG... |
Task1_train_10889 | A sequence alteration has been identified in TBXT (T-box transcription factor T) on Chromosome 6. Is it disease-inducing or harmless? | Pathogenic; Sacral agenesis-abnormal ossification of the vertebral bodies-persistent notochordal canal syndrome | GGCTTCAATTTCCAAACTACTAACAATTCTCCAGGCAGCACTGGAAGGAAGGGTGCAGACGTGCCCTGGCTGCCCAGCCGGCCCTGGCCAGAGCAGTGGCTCACTCTACTCAAGTGACTGCCTTTCTGGTTGTTCAATCAGCCTAGGAAATGATGAAAAATCTACAGAATAGAAAATGCCTGTGTAAGGAGGAGTGTGCCCTGTTGATTCATCCAGCCTCTTGACCAGCCAGTGCTACCGCGTTCATTGTTTAATATCTCCAAGTCCCTTCCCCGGGTGGAGAGGACGGACCAGGATGAGAGAGAGCGTTTCTCCCAACA... | GGCTTCAATTTCCAAACTACTAACAATTCTCCAGGCAGCACTGGAAGGAAGGGTGCAGACGTGCCCTGGCTGCCCAGCCGGCCCTGGCCAGAGCAGTGGCTCACTCTACTCAAGTGACTGCCTTTCTGGTTGTTCAATCAGCCTAGGAAATGATGAAAAATCTACAGAATAGAAAATGCCTGTGTAAGGAGGAGTGTGCCCTGTTGATTCATCCAGCCTCTTGACCAGCCAGTGCTACCGCGTTCATTGTTTAATATCTCCAAGTCCCTTCCCCGGGTGGAGAGGACGGACCAGGATGAGAGAGAGCGTTTCTCCCAACA... |
Task1_train_10890 | This mutation is located in gene MPC1 (mitochondrial pyruvate carrier 1) on Chromosome 6. Is it associated with a disease or is it a benign polymorphism? | Pathogenic; Mitochondrial pyruvate carrier deficiency | GAAGCAGGCAGATCACTTGAGGCCAGGAGTTCAGGACCATCCTGGCCAACATGGCAAAACCCCGCCTCTACTAAAAATACAAAAATTAGTCGGGTATGGTGGCGCATGCCTGTAATCCCAGCTACTTGGGAGGCTGAGGCAGAAGAATCACTTGAATCCAGGAGGTGGAGGTTGCAGTGAACTGTGATTGCACCACTGCACTCCAGCCTGGGCCACAGAGTGAGACCCTGTCTCAAAAGTGACAGAATATGGACCCTTGAGGGAGACTGCGCCTCACAGACTTCCCCTCTGCTCATCACGGGCTTCTCTGCTGCCCTCAT... | GAAGCAGGCAGATCACTTGAGGCCAGGAGTTCAGGACCATCCTGGCCAACATGGCAAAACCCCGCCTCTACTAAAAATACAAAAATTAGTCGGGTATGGTGGCGCATGCCTGTAATCCCAGCTACTTGGGAGGCTGAGGCAGAAGAATCACTTGAATCCAGGAGGTGGAGGTTGCAGTGAACTGTGATTGCACCACTGCACTCCAGCCTGGGCCACAGAGTGAGACCCTGTCTCAAAAGTGACAGAATATGGACCCTTGAGGGAGACTGCGCCTCACAGACTTCCCCTCTGCTCATCACGGGCTTCTCTGCTGCCCTCAT... |
Task1_train_10891 | Here is a mutation in MPC1 (mitochondrial pyruvate carrier 1) on Chromosome 6. Determine whether it’s benign or pathogenic. If the latter, what disease does it cause? | Pathogenic; Mitochondrial pyruvate carrier deficiency | GCAAAACCCCGCCTCTACTAAAAATACAAAAATTAGTCGGGTATGGTGGCGCATGCCTGTAATCCCAGCTACTTGGGAGGCTGAGGCAGAAGAATCACTTGAATCCAGGAGGTGGAGGTTGCAGTGAACTGTGATTGCACCACTGCACTCCAGCCTGGGCCACAGAGTGAGACCCTGTCTCAAAAGTGACAGAATATGGACCCTTGAGGGAGACTGCGCCTCACAGACTTCCCCTCTGCTCATCACGGGCTTCTCTGCTGCCCTCATCTGCTACCACATAGAGAATGGGAAACTATAATCAGATTCAAGTTGGATTTTTT... | GCAAAACCCCGCCTCTACTAAAAATACAAAAATTAGTCGGGTATGGTGGCGCATGCCTGTAATCCCAGCTACTTGGGAGGCTGAGGCAGAAGAATCACTTGAATCCAGGAGGTGGAGGTTGCAGTGAACTGTGATTGCACCACTGCACTCCAGCCTGGGCCACAGAGTGAGACCCTGTCTCAAAAGTGACAGAATATGGACCCTTGAGGGAGACTGCGCCTCACAGACTTCCCCTCTGCTCATCACGGGCTTCTCTGCTGCCCTCATCTGCTACCACATAGAGAATGGGAAACTATAATCAGATTCAAGTTGGATTTTTT... |
Task1_train_10892 | Assess the clinical impact of this variant on gene RNASET2 (ribonuclease T2), found on Chromosome 6. State whether it’s pathogenic or benign, and the disease if applicable. | Pathogenic; Cystic leukoencephalopathy without megalencephaly | TAGGGCAGGAGGGGCAAAGTCACCGTTCTAGGACACACCTGTGACCACACCAGGCCTCCAACAACGGAGCAGCTGGCTAAGGAACGATGTCCTGGGGCTCTGGTCACATGGAACAGACCCAGTCTGAGCTAGAGACACCCCCCAGGCCCACCAGGCATCAGCGTGGGCTCCTGCCATGCGTGGAGCTCTTCGTCTTGACAGGGTCCCTGCGCCAAGAAGGCAACAGGCTCCGAGGGGAAAACTCGAGCAAGAGAGTCCCCTGAATCGGTGCCATCTGTCTAAATTCCAAGTATGCCTGCCTGATCTACCAGGGCACTGAA... | TAGGGCAGGAGGGGCAAAGTCACCGTTCTAGGACACACCTGTGACCACACCAGGCCTCCAACAACGGAGCAGCTGGCTAAGGAACGATGTCCTGGGGCTCTGGTCACATGGAACAGACCCAGTCTGAGCTAGAGACACCCCCCAGGCCCACCAGGCATCAGCGTGGGCTCCTGCCATGCGTGGAGCTCTTCGTCTTGACAGGGTCCCTGCGCCAAGAAGGCAACAGGCTCCGAGGGGAAAACTCGAGCAAGAGAGTCCCCTGAATCGGTGCCATCTGTCTAAATTCCAAGTATGCCTGCCTGATCTACCAGGGCACTGAA... |
Task1_train_10893 | A variant was discovered in gene ERMARD (ER membrane associated RNA degradation), Chromosome 6. Please indicate if this mutation results in a known disease or if it's non-harmful. | Pathogenic; Periventricular nodular heterotopia 6 | TGTGTACACAAACACACATGCACATACCACACATACACACACACACATGAACACATACCTCCATGCCACACAGACACACACAGGCATACACATACTCTAATGTGTACACAACACACATGCACACACCACACACGAACTCACACATCCATGCCACATATACACACACAGGCATACACACATGCAGGCACATACACTACACACACACACACACACACACACAGGCACAGTTGCATATAAACACACAAATGTACACACCCCCACACCACATATGCACATACACATATACACACCACACATATTCATAGTCACATACACAAACA... | TGTGTACACAAACACACATGCACATACCACACATACACACACACACATGAACACATACCTCCATGCCACACAGACACACACAGGCATACACATACTCTAATGTGTACACAACACACATGCACACACCACACACGAACTCACACATCCATGCCACATATACACACACAGGCATACACACATGCAGGCACATACACTACACACACACACACACACACACACAGGCACAGTTGCATATAAACACACAAATGTACACACCCCCACACCACATATGCACATACACATATACACACCACACATATTCATAGTCACATACACAAACA... |
Task1_train_10894 | This variant lies on Chromosome 6 and affects the gene PSMB1 (proteasome 20S subunit beta 1). Based on this context, is the mutation pathogenic or benign? If pathogenic, what disease does it cause? | Pathogenic; Neurodevelopmental disorder with microcephaly, hypotonia, and absent language | AAAGAACACTTAAAAGCCAACCAGACAGACAAGCTTAGAAAGACAGTTCTAGAGACACCTGAGGTTGTCACCAAAACTAGCAACACTGTTACATGGAAATCAAAGAACAGGGCTCTGAAGTGAAACAAAAGCCAAACCTGAATCTTAGGTCTGCTGCTTAGTAGGTATCAGCTTTCCCAGATTAGACTCTCTAACTCTCGGAAAAACTCAAAGGATGCTGTCTGGCCTGCTGAAATTCAATGGCAGCTCAGCTATTTTTAATGTTGCTAAAATCTGAATCTATTAATCTGACATTAAAGCCAGGCATAATGTAAGTCAAA... | AAAGAACACTTAAAAGCCAACCAGACAGACAAGCTTAGAAAGACAGTTCTAGAGACACCTGAGGTTGTCACCAAAACTAGCAACACTGTTACATGGAAATCAAAGAACAGGGCTCTGAAGTGAAACAAAAGCCAAACCTGAATCTTAGGTCTGCTGCTTAGTAGGTATCAGCTTTCCCAGATTAGACTCTCTAACTCTCGGAAAAACTCAAAGGATGCTGTCTGGCCTGCTGAAATTCAATGGCAGCTCAGCTATTTTTAATGTTGCTAAAATCTGAATCTATTAATCTGACATTAAAGCCAGGCATAATGTAAGTCAAA... |
Task1_train_10895 | The following genetic variant occurs in FAM20C (FAM20C golgi associated secretory pathway kinase) on Chromosome 7. Classify its clinical effect — pathogenic or benign — and list any associated condition. | Pathogenic; Lethal osteosclerotic bone dysplasia | TCGGTCCGAGTCGCCCCCCGGCCCCGGCGGAGACGCCTCCCTCCTGGCCAGGCTGTTCGAGCACCCGCTTTACCGGGTGGCGGTTCCGCCGCTCACGGAGGAGGACGTCCTGTTCAATGTGAACAGCGACACCAGGCTCAGCCCCAAAGCGGCGGAGAACCCGGACTGGTGAGTGGGGGCTGGCAGGTGCCCACCCCCAAGGGAGCCGTGAGCCCAAGGCATGGTGTAGAGAGGTTCAGGGGCCCCAGAGGGCCGCCCCCCATGGAAGAGGCCGGGCAGGGAGTGTGGTGCGGGAGGAGGCAGCCGCCTACCTCAGGGCG... | TCGGTCCGAGTCGCCCCCCGGCCCCGGCGGAGACGCCTCCCTCCTGGCCAGGCTGTTCGAGCACCCGCTTTACCGGGTGGCGGTTCCGCCGCTCACGGAGGAGGACGTCCTGTTCAATGTGAACAGCGACACCAGGCTCAGCCCCAAAGCGGCGGAGAACCCGGACTGGTGAGTGGGGGCTGGCAGGTGCCCACCCCCAAGGGAGCCGTGAGCCCAAGGCATGGTGTAGAGAGGTTCAGGGGCCCCAGAGGGCCGCCCCCCATGGAAGAGGCCGGGCAGGGAGTGTGGTGCGGGAGGAGGCAGCCGCCTACCTCAGGGCG... |
Task1_train_10896 | A variant was discovered in gene FAM20C (FAM20C golgi associated secretory pathway kinase), Chromosome 7. Please indicate if this mutation results in a known disease or if it's non-harmful. | Pathogenic; Lethal osteosclerotic bone dysplasia | CCCTGAGGAGGCTGGAGCTCCACCGCATTTTTCATATGAGGAACCCAGCACGTCCCGCCTGCCTCCGGCCCCTGGAGGCTTTCTCAGTGACAAACCGTTTCTGTTTCTGTCTTGTTTTCTCAGACAAACGAGGGAGCAGGAGACACCCCCTGACTTTTTTTATTTCTCTGACTACGAGAGGCACAATGCGGAGATTGCTGCCTTCCACCTGGACAGGTGAGCCCTTCCTTCCTCCCTCCATCCGCGCTCCCGTGCGCTCAGACCCACCGGTGAGTGAGGCCGTCCTGCACTGGACACAGCAGGACGTCATCGTCACCTTC... | CCCTGAGGAGGCTGGAGCTCCACCGCATTTTTCATATGAGGAACCCAGCACGTCCCGCCTGCCTCCGGCCCCTGGAGGCTTTCTCAGTGACAAACCGTTTCTGTTTCTGTCTTGTTTTCTCAGACAAACGAGGGAGCAGGAGACACCCCCTGACTTTTTTTATTTCTCTGACTACGAGAGGCACAATGCGGAGATTGCTGCCTTCCACCTGGACAGGTGAGCCCTTCCTTCCTCCCTCCATCCGCGCTCCCGTGCGCTCAGACCCACCGGTGAGTGAGGCCGTCCTGCACTGGACACAGCAGGACGTCATCGTCACCTTC... |
Task1_train_10897 | The following genetic variant occurs in FAM20C (FAM20C golgi associated secretory pathway kinase) on Chromosome 7. Classify its clinical effect — pathogenic or benign — and list any associated condition. | Pathogenic; Lethal osteosclerotic bone dysplasia | CATCTGAAACCGGCTTAGGCGAGGACGGGAGGCTGTTAACAGCAGACGAATTTTAAGCCTCCAGCCAATGAGCGCTCAGATGAAGATTTTCCTCCTGAAATGGAGCTCCTGCCCCGGTGGGGGCTGCCTCGTCCGACTGTGGGCTGCCGACTAATCTGTATCAGCACGAGACAGGATTGCAGCTGGTCTTTCCTTGATCGTTCGTTCTTACAATAATGACCCAGCGTTGGCAGTGGGGTGAGGGGGCGCGGGAAGGAGGGGGCAGGCAGGTGATCGGGGCGTTGGAACCAGACCAGCCGGGACCTGCCGGGTGCGTGGGG... | CATCTGAAACCGGCTTAGGCGAGGACGGGAGGCTGTTAACAGCAGACGAATTTTAAGCCTCCAGCCAATGAGCGCTCAGATGAAGATTTTCCTCCTGAAATGGAGCTCCTGCCCCGGTGGGGGCTGCCTCGTCCGACTGTGGGCTGCCGACTAATCTGTATCAGCACGAGACAGGATTGCAGCTGGTCTTTCCTTGATCGTTCGTTCTTACAATAATGACCCAGCGTTGGCAGTGGGGTGAGGGGGCGCGGGAAGGAGGGGGCAGGCAGGTGATCGGGGCGTTGGAACCAGACCAGCCGGGACCTGCCGGGTGCGTGGGG... |
Task1_train_10898 | The gene FAM20C (FAM20C golgi associated secretory pathway kinase) on Chromosome 7 carries this variant. Does this mutation lead to a specific disease, or is it non-pathogenic? | Pathogenic; Lethal osteosclerotic bone dysplasia | ATCTGAAACCGGCTTAGGCGAGGACGGGAGGCTGTTAACAGCAGACGAATTTTAAGCCTCCAGCCAATGAGCGCTCAGATGAAGATTTTCCTCCTGAAATGGAGCTCCTGCCCCGGTGGGGGCTGCCTCGTCCGACTGTGGGCTGCCGACTAATCTGTATCAGCACGAGACAGGATTGCAGCTGGTCTTTCCTTGATCGTTCGTTCTTACAATAATGACCCAGCGTTGGCAGTGGGGTGAGGGGGCGCGGGAAGGAGGGGGCAGGCAGGTGATCGGGGCGTTGGAACCAGACCAGCCGGGACCTGCCGGGTGCGTGGGGT... | ATCTGAAACCGGCTTAGGCGAGGACGGGAGGCTGTTAACAGCAGACGAATTTTAAGCCTCCAGCCAATGAGCGCTCAGATGAAGATTTTCCTCCTGAAATGGAGCTCCTGCCCCGGTGGGGGCTGCCTCGTCCGACTGTGGGCTGCCGACTAATCTGTATCAGCACGAGACAGGATTGCAGCTGGTCTTTCCTTGATCGTTCGTTCTTACAATAATGACCCAGCGTTGGCAGTGGGGTGAGGGGGCGCGGGAAGGAGGGGGCAGGCAGGTGATCGGGGCGTTGGAACCAGACCAGCCGGGACCTGCCGGGTGCGTGGGGT... |
Task1_train_10899 | The gene FAM20C (FAM20C golgi associated secretory pathway kinase) is located on Chromosome 7, where a mutation has occurred. What is the medical relevance of this mutation? | Pathogenic; FAM20C-related disorder | CAGACGAATTTTAAGCCTCCAGCCAATGAGCGCTCAGATGAAGATTTTCCTCCTGAAATGGAGCTCCTGCCCCGGTGGGGGCTGCCTCGTCCGACTGTGGGCTGCCGACTAATCTGTATCAGCACGAGACAGGATTGCAGCTGGTCTTTCCTTGATCGTTCGTTCTTACAATAATGACCCAGCGTTGGCAGTGGGGTGAGGGGGCGCGGGAAGGAGGGGGCAGGCAGGTGATCGGGGCGTTGGAACCAGACCAGCCGGGACCTGCCGGGTGCGTGGGGTGTGGTGGGGGCCAGGTCGGCCTGGCACCCACCCCGTTTCCT... | CAGACGAATTTTAAGCCTCCAGCCAATGAGCGCTCAGATGAAGATTTTCCTCCTGAAATGGAGCTCCTGCCCCGGTGGGGGCTGCCTCGTCCGACTGTGGGCTGCCGACTAATCTGTATCAGCACGAGACAGGATTGCAGCTGGTCTTTCCTTGATCGTTCGTTCTTACAATAATGACCCAGCGTTGGCAGTGGGGTGAGGGGGCGCGGGAAGGAGGGGGCAGGCAGGTGATCGGGGCGTTGGAACCAGACCAGCCGGGACCTGCCGGGTGCGTGGGGTGTGGTGGGGGCCAGGTCGGCCTGGCACCCACCCCGTTTCCT... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.